The QualityStocks Daily Monday, October 28th, 2024

Today's Top 3 Investment Newsletters

Premium Stock Alerts(HCTI) $1.3000 +124.53%

360 Wall Street(GLUE) $9.4800 +93.87%

SmallCapRelations(GNPX) $2.7400 +38.38%

The QualityStocks Daily Stock List

Evoke Pharma Inc. (EVOK)

MarketBeat, Kiplinger Today, Jason Bond, TradersPro, QualityStocks, BUYINS.NET, StockMarketWatch, Marketbeat.com, Daily Trade Alert, Streetwise Reports, StreetInsider, Penny Stock Prodigy, StockEarnings, TopPennyStockMovers, TraderPower, InvestorPlace, Short Term Wealth, Investing Futures, Money Wealth Matters, Barchart, Seeking Alpha, Trades Of The Day, Stock Market Watch, Street Insider, The Online Investor, The Wealth Report and Schaeffer's reported earlier on Evoke Pharma Inc. (EVOK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Evoke Pharma Inc. (NASDAQ: EVOK) (FRA: EV0) is a pharmaceutical firm that is engaged in the manufacture, development and commercialization of therapies that can treat gastroenterological ailments and disorders.

The firm has its headquarters in Solana Beach, California and was incorporated in January 2007 by David A. Gonyer, Scott L. Glenn, Cam L. Garner and Matthew J. D’Onofrio. The firm serves consumers in the United States.

The enterprise markets its products to select health care providers, primary care physicians, internal medicine specialists and gastroenterologists. Its product pipeline is made up of a metoclopramide nasal spray known as Gimoti, which has concluded phase 3 clinical trials testing its effectiveness in treating symptoms linked to recurrent and acute diabetic gastroparesis in females. This gastrointestinal disorder hinders the stomach from emptying its contents at the appropriate time, which results in severe digestive system symptoms. It affects millions globally. The spray formulation, which is a mixed 5-HT3 and 5-HT4 antagonist, has anti-emetic and promotility effects and has been designed to offer systemic delivery of the molecule via the nasal mucosa. Before this formulation was developed, metoclopramide was the sole drug available in the U.S. indicated for the treatment of gastroparesis. The drug was only available in intravenous and oral forms.

The company recently announced its financial results for 2021’s second quarter, with its CEO noting that they were focused on driving the company’s marketing and commercial initiatives forward and making Gimoti the preferred treatment option for diabetic gastroparesis patients, which would not only bring in investment opportunities into the firm but also extend its consumer reach, which would be good for the company’s growth.

Evoke Pharma Inc. (EVOK), closed Monday's trading session at $7.08, up 33.5849%, on 21,131,703 volume. The average volume for the last 3 months is 18.069M and the stock's 52-week low/high is $3.54/$17.88.

CBD Life Sciences, Inc. (CBDL)

QualityStocks, StockRockandRoll, PennyStockLocks, Penny Stock 101 and FreeRealTime reported earlier on CBD Life Sciences, Inc. (CBDL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

CBD Life Sciences, Inc.’s principal focus is to identify, evaluate and acquire undervalued opportunities with the aim of increasing shareholder value. The acquisition of LBC Bioscience, Inc. is the first in the CBD space. The Company is actively searching for additional opportunities within this developing sector. CBD Life Sciences lists on the OTC Markets. The Company is headquartered in Scottsdale, Arizona.

CBD Life Sciences announced this past March, that its wholly-owned subsidiary, LBC Bioscience, finalized the formulization for and is launching an organic - GMO free – CBD (cannabidiol) based anti-aging product line. The product line includes anti-aging day serum, CBD based eye gel, nourishing face serum with retinol, blemish balancing serum, CBD vitamin C face serum, and CBD based face cream. In addition, LBC Bioscience is working with Dr. Farhan Taghizadeh of Arizona Facial Plastics P.C. to develop a case study showing the effectiveness of the product line.

LBC Bioscience has also entered into negotiations to distribute its line of products in Japan. The initial order is $250,000. Ms. Lisa Nelson, President & Chief Executive Officer of CBD Life Sciences’ said this past April, “We are very excited about this opportunity to enter the Japanese market. The Japanese have embraced the benefits of CBD and we want to be on the forefront providing quality products to this aggressive expanding market.”

CBD Life Sciences previously announced that its LBC Bioscience completed the development of a disposable CBD vape-pen. This product is now undergoing final market testing. The anticipation is that it will be available for purchase within the next three to four weeks. LBC Bioscience is positioning itself to be a leader in the specialized CBD + e-cigarette vaping market.

Recently, CBD Life Sciences announced that LBC Bioscience is continuing to experience substantial revenue growth due to the expansion and market acceptance of its product lines. LBC is experiencing growth in retail sales. Moreover, it now being approached to provide ‘white label’ versions of its product lines. LBC Bioscience has developed and is retailing/wholesaling a complete line of cannabidiol based organic products. These include hemp drops, massage oils, pain relief creams, anxiety and sleep supplements, CDB edibles, anti-aging skin solutions and a full line of CBD infused supplements for pets.

CBD Life Sciences, Inc. (CBDL), closed Monday's trading session at $0.0017, up 21.4286%, on 80,377,770 volume. The average volume for the last 3 months is 864,332 and the stock's 52-week low/high is $0.0003/$0.03.

Quantum Computing, Inc. (QUBT)

QualityStocks, InvestorPlace, MarketClub Analysis, TradersPro and BUYINS.NET reported earlier on Quantum Computing, Inc. (QUBT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Quantum Computing, Inc. is a technology company based in Leesburg Virginia. It focuses on developing novel applications and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries.

The Company has put together a world-class team of experts in supercomputing, technology, defense, and government. This team is working to develop solutions to world-class problems. It is developing processes to commercialize advances in quantum computing.

Quantum Computing is leveraging its collective expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial and security sectors. It is developing a variety of software applications capable of running on quantum and quantum-inspired hardware from numerous vendors. The Company’s initial emphasis is on the creation of Quantum Finance applications.

Mukai is Quantum Computing’s proprietary middleware environment for developing applications to address complex optimization problems that are NP-hard, often involving multi-dimensional solution spaces with thousands if not hundreds of thousands of variables. The software stack contained in Mukai enables developers to create and deploy applications with superior performance on classical computers and future quantum computers.

Regarding Quantum Asset Allocator, Fund Managers can now use the Company’s quantum asset allocator to take advantage of quantum-inspired techniques to solve the NP-hard problems preventing them from truly optimal portfolio optimization. Concerning Community Detection, the Quantum Community Detector utilizes advanced graph analytics with quantum-inspired techniques to deliver insights into big data structures.

Quantum Computing, Inc. (QUBT), closed Monday's trading session at $1.28, up 17.4312%, on 5,174,285 volume. The average volume for the last 3 months is 4.283M and the stock's 52-week low/high is $0.3549/$1.32.

Hut 8 Mining Corp. (HUT)

Schaeffer's, MarketClub Analysis, StocksEarning, StockEarnings, RedChip, MarketBeat, InvestorPlace, The Street, QualityStocks, Kiplinger Today, The Online Investor, Zacks, Trades Of The Day, AllPennyStocks, Early Bird and Daily Trade Alert reported earlier on Hut 8 Mining Corp. (HUT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Hut 8 Mining Corp. (NASDAQ: HUT) (TSE: HUT) (OTC: HUTWF) (FRA: 1YT) is a blockchain infrastructure and cryptocurrency mining firm that provides blockchain infrastructure and technology solutions.

The firm has its headquarters in Toronto, Canada and was incorporated in 2011, on June 9th by Andrew Kiguel. It operates as part of the software and tech services industry, in the technology sector, under the technology services sub-industry and serves consumers in North America.

The company was established through an exclusive partnership with one of the leading blockchain technology firms in the world, Bitfury. It is led by a team of industry experts who offer investors exposure to blockchain technology and blockchain processing infrastructure, together with cryptocurrency revenue from transaction fees and rewards.

The enterprise is in the business of using specialized equipment to work out complex computational problems that validate transactions on the bitcoin blockchain. Currently, the enterprise owns bitcoin mining data centers representing 165 PH/s and 24.2 MW, which are either under construction or in operation, with a pipeline of development and acquisition opportunities across North America. It also operates and owns over 50 BlockBoxes in Alberta’s Medicine Hat and more than 30 BlockBoxes in Drumheller, which is also located in Alberta. It receives bitcoin as payment for the commercial activity of bitcoin mining.

The firm recently purchased 11,090 M31S, M30S+ and M30S miners, which will be in full deployment by December 2021. This will increase the production capacity and allow the firm to double its hashrate before 2021 ends, which will also significantly increase the number of Bitcoins earned daily. The move is bound to also increase the firm’s revenue, which in turn increases its profits.

Hut 8 Mining Corp. (HUT), closed Monday's trading session at $17.21, up 15.5034%, on 8,626,529 volume. The average volume for the last 3 months is 3.377M and the stock's 52-week low/high is $6.18/$21.0983.

HIVE Blockchain Technologies (HIVE)

QualityStocks, InvestorPlace, MarketClub Analysis, MarketBeat, CryptoCurrencyWire, Zacks, StreetInsider, Early Bird, Marketbeat.com, StockMarketWatch, Stock Market Watch, Greenbackers, Hit and Run Candle Sticks, Barchart, smartOTC, StockOodles, StreetAuthority Daily, The Night Owl, The Online Investor, TopStockAnalysts, Wall Street Resources, WealthMakers and Schaeffer's reported earlier on HIVE Blockchain Technologies (HIVE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

HIVE Blockchain Technologies Ltd (NASDAQ: HIVE) (CVE: HIVE) (FRA: HBF) is a crypto currency mining firm that is focused on building bridges between the blockchain sector and traditional capital markets.

The firm has its headquarters in Vancouver, Canada and was incorporated in 1987, on June 24th. Prior to its name change in September 2017, the firm was known as Leeta Gold Corp. It serves consumers around the globe.

The company is focused on being the leading listed blockchain infrastructure firm by accelerating the development of the blockchain sector. It operates through the Norway, Switzerland, Iceland, Sweden and Canada geographical segments. The majority of the company’s revenue is generated from Canada. The company offers its shareholders a portfolio of crypto-coins as well as operating margins of digital currency mining.

The enterprise is involved in the sale and mining of digital currencies. It validates transactions on blockchain networks. It also owns state-of-the-art green energy-powered data center facilities in Iceland, Sweden and Canada which generate minted digital currencies like Ethereum and Bitcoin on the cloud, around the clock. The enterprise’s projects include Iceland Crypto currency mining. In addition to this, it also owns a data center campus in New Brunswick.

The company recently released its annual report for the year ended March 2021 which shows significant increases in the company’s net income and gross mining margin. It is now focused on improving its profitability and efficiency across its mining operations by maximizing its infrastructure and electrical capacity through the installation of new mining equipment, lowering its costs and optimizing crypto currency mining output.

HIVE Blockchain Technologies (HIVE), closed Monday's trading session at $4.11, up 13.2231%, on 5,987,909 volume. The average volume for the last 3 months is 2.192M and the stock's 52-week low/high is $2.18/$5.74.

Jiade Limited (JDZG)

Premium Stock Alerts and MarketClub Analysis reported earlier on Jiade Limited (JDZG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Jiade Limited (NASDAQ: JDZG) is a company engaged in the provision of education-supporting services to adult education institutions through a spectrum of software platforms and auxiliary solutions.

The firm has its headquarters in Chengdu, China and was incorporated in 2023, on February 20th. It operates as part of the information technology services industry, under the technology sector. The firm serves consumers primarily in the People’s Republic of China.

The company places a great premium on technology research and development.Thus far, its subsidiaries have acquired 31 software copyrights since their incorporation in April 2020. Kebiao Technology, one of its subsidiaries, has also been designated a High and New Technology Enterprise by Sichuan Provincial Department of Science and Technology.

The enterprise’s Kebiao Technology Educational Administration Platform (KB Platform) facilitates streamlined information and data management throughout the teaching cycle of adult education services, from the pre-enrollment period and even after graduation. The platform supports a range of services, such as enrollment consultation, student information collection, enrollment status management, learning progress management, grade inquiry, and graduation management. It also provides offline tutoring, exam administration services, guidance on graduation thesis; pre-enrollment guidance on school/selection and application strategy development, training for entrance exams, and assistance in the application process; and social practice assistance, including education supporting services.

The company, which recently closed its initial public offering, remains committed to better meeting the evolving needs of their customers in the rapidly changing adult education industry. This is in addition to generating additional value for its shareholders.

Jiade Limited (JDZG), closed Monday's trading session at $1.43, up 2.1429%, on 630,236 volume. The average volume for the last 3 months is 3.154M and the stock's 52-week low/high is $0.4488/$15.0799.

Nikola Corporation (NKLA)

Green Car Stocks, Schaeffer's, StockEarnings, InvestorPlace, QualityStocks, MarketClub Analysis, StocksEarning, MarketBeat, The Street, Early Bird, Kiplinger Today, Trades Of The Day, StreetInsider, Daily Trade Alert, The Online Investor, GreenCarStocks, Zacks, Cabot Wealth, Louis Navellier, CNBC Breaking News, Wealth Insider Alert, Investopedia, Premium Stock Alerts, MarketTamer, InvestorsUnderground, INO Market Report, BillionDollarClub, Prism MarketView, Daily Profit, Outsider Club, DividendStocks, TipRanks, Earnings360, The Wealth Report, Green Energy Stocks, AllPennyStocks, StockMarketWatch and Daily Wealth reported earlier on Nikola Corporation (NKLA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Nikola Corporation (NASDAQ: NKLA)‘s stock rose 4.03%  last week due to the deployment of hydrogen-powered trucks in Illinois. The surge stems from a key partnership between Nikola, Diageo, and DHL Supply Chain, signifying a noteworthy expansion beyond Nikola’s established presence on the West Coast. By targeting the Midwest, the company is trying to establish itself as a leader in sustainable, hydrogen-fueled transport across the United States.

In this recent agreement, Nikola rolled out two hydrogen-powered trucks to support Diageo and DHL Supply Chain operations within Illinois. In addition to these trucks, Nikola has installed a modular refueling station on Diageo’s campus in Plainfield, Illinois. This infrastructure investment allows hydrogen vehicles to operate easily and reflects Nikola’s commitment to building a cleaner, nationwide fuel network. Such infrastructure is essential for companies like DHL to meet eco-friendly targets. The expansion into Illinois represents the American manufacturer’s goal to diversify and strengthen its market presence, a move that has drawn strong investor interest.

Even with the good progress it is facing, Nikola is still dealing with serious money problems. Its stock is currently valued at $4.39, with a market capitalization of $222.12 million. Some investors might see the company as undervalued, as reflected in a price-to-book (P/B) ratio of 0.41, a figure close to Nikola’s five-year low. This ratio could be an indicator of potential buying opportunity when a company’s market price is notably lower than its net assets. However, the Phoenix based company’s financial profile remains risky and potential investors should really consider whether taking these risks is worth it.

One significant caution comes from Nikola’s Altman Z-score of -6.18, a metric that suggests a high risk of financial distress within the next two years. In the last three years, Nikola has taken on $617.783 million in debt while also issuing $715.894 million in new shares. As a result of this strategy, existing shareholders are seeing their shares diluted, affecting their value. Therefore potential investors should consider this dilution effect as it can often lower the appeal of a stock.

On a positive note, Nikola’s Beneish M-Score stands at -3.79, suggesting that the company is unlikely to be manipulating its financial statements. The score gives a clear view of the situation and may reassure investors who want financial reporting stability, which is especially important given Nikola’s challenging financial position.

All in all, the expansion of Nikola into Illinois shows clear growth potential, though the company’s financial challenges suggest caution. The recent stock surge reflects both optimism about Nikola’s new partnerships and concerns about its financial health, making it essential for investors to proceed carefully.

Nikola Corporation (NKLA), closed Monday's trading session at $5.31, up 20.1357%, on 10,812,099 volume. The average volume for the last 3 months is 8.192M and the stock's 52-week low/high is $3.72/$38.40.

Coinbase Global Inc. (COIN)

Schaeffer's, InvestorPlace, QualityStocks, MarketClub Analysis, The Street, Zacks, Prfmonline, MarketBeat, StockEarnings, Greenbackers, Early Bird, Kiplinger Today, INO Market Report, Investopedia, OTCPicks, SmallCapVoice, The Online Investor, Ceocast News, The Wealth Report, InsiderTrades, CoolPennyStocks, HotOTC, Daily Trade Alert, StockEgg, StocksEarning, Trades Of The Day, Jeff Bishop, Penny Invest, Stock Stars, TradersPro, CryptoCurrencyWire, FreeRealTime, Stock Rich, Top Pros' Top Picks, BestOtc, The Stock Psycho, Investors Underground, Top Gun, CNBC Breaking News, BullRally, HotShotStocks, BillionDollarClub, Wealth Daily, StockHotTips, MadPennyStocks, FeedBlitz, Energy and Capital, Cabot Wealth, Today's Financial News, Eagle Financial Publications, Louis Navellier, DividendStocks, Smartmoneytrading, PennyStockVille, MarketClub Options, StockRich, Stockpalooza, Profit Confidential, PennyInvest, Summa Money, bullseyeoptiontrading, PennyTrader Publisher, AlphaShark Trading, Dawn Report, Atomic Trades, wealthmintrplus, Stock Fortune Teller, WiseAlerts, wyatt research newsletter, Blaque Capital Stocks, BloomMoney, CRWEWallStreet, Standout Stocks, Round Up the Bulls, StockMister, Pennybuster, Penny Stock Rumble, AllPennyStocks, Momentum Traders, MicrocapVoice, TradingPub, InvestorsUnderground, Dynamic Wealth Report, Penny Stock Finder, Stock Traders Chat, Trading with Larry Benedict, Green Chip Stocks, Stock Analyzer, Early Investing, Wealth Whisperer and TipRanks reported earlier on Coinbase Global Inc. (COIN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The U.S. Securities and Exchange Commission (SEC) will continue prioritizing crypto as part of its 2025 examination agenda, despite possible leadership and government oversight shifts.

The commission’s Division of Examinations announced on October 21 its priorities for the new year, with a particular emphasis on digital assets and related services and products. The SEC plans to scrutinize crypto activities, such as their offering, selling, trading, and advertising, with particular attention on spot Ether and Bitcoin ETFs. The SEC first greenlit Bitcoin spot ETFs in January, followed by the approval of Ether spot ETFs in May.

The division highlighted that given the fluctuating nature and significant activity in crypto markets, it will continue to conduct examinations of firms offering crypto-related services. This approach aims to address the technological challenges tied to blockchain, including securing crypto assets against potential risks.

According to the division’s acting director, Keith Cassidy, the priorities list identifies areas that could pose increased risks to investors. He suggested that the SEC’s stance on digital assets would remain consistent in 2025, reinforcing a steady approach. SEC Chair Gary Gensler also echoed this sentiment, noting that the division aims to help market participants understand regulatory expectations while maintaining investor protection and enabling capital growth.

The SEC has come under fire for its regulatory posture under Gensler’s direction, especially for its enforcement-oriented strategy, which has led to legal actions against several crypto companies. Additionally, the regulator has issued Wells Notices to companies such as Uniswap and OpenSea in the past year, deeming some of their services as securities offerings, which could lead to potential legal action.

However, a recent ruling by the Supreme Court in June that reversed the long-standing Chevron theory could have an impact on the SEC’s future legal position in these cases. However, the agency still has proceedings pending against companies like Coinbase Global Inc. (NASDAQ: COIN) and Ripple, among others.

While Gensler’s term officially extends to June 2026, some experts speculate he may step down in early 2025 if a new presidential administration assumes office. During a Bitcoin conference in July, GOP candidate Donald Trump stated his intent to replace him on the first day in office if re-elected. Reports also suggest that Vice President Kamala Harris, the Democratic candidate, might consider alternatives for the role.

Both candidates have attracted substantial donations from prominent figures in the crypto sector. For instance, Chris Larsen has contributed over $10 million to Harris’s campaign, while Donald Trump has reportedly received over $7.5 million in donations from the crypto community.

Coinbase Global Inc. (COIN), closed Monday's trading session at $216.1, up 5.3941%, on 10,458,713 volume. The average volume for the last 3 months is 1.379M and the stock's 52-week low/high is $71.88/$283.48.

Momo Inc. (MOMO)

QualityStocks, StocksEarning, MarketClub Analysis, StockEarnings, InvestorPlace, Schaeffer's, Marketbeat, Market Intelligence Center Alert, Zacks, The Street, Trades Of The Day, Kiplinger Today, Daily Trade Alert, StreetInsider, The Street Report, Marketbeat.com, FreeRealTime, BUYINS.NET, The Online Investor, INO.com Market Report, ChineseWire, TipRanks, Louis Navellier, TradersPro, Trading Concepts, Wealth Insider Alert, StreetAuthority Daily, TopStockAnalysts, Investopedia, Money Morning, DividendStocks, Daily Wealth, PennyDoctor, Greenbackers, StockMarketWatch, StocksImpossible, Street Insider, OTCBB Journal, Early Bird, First Penny Picks, ChartAdvisor, Barchart, CrashTrade, Investing Signal, InvestmentHouse, Jason Bond, AskSlapper, Orbit Stocks, Profit Confidential, Promotion Stock Secrets, Short Term Wealth, Terry's Tips, The Best Newsletters, The Stock Dork and One Hot Stock reported earlier on Momo Inc. (MOMO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Italian fintech app Tinaba alongside Banca Profilo will become the first fintech company in Europe to incorporate Alipay+ Mini Program solutions. The move also makes Tinaba one of the first Super Apps in the European market and will revolutionize mobile money services for both merchants and users.

Integrating the Alipay+ technology into Tinaba will allow the leading Italian application to design an open system/platform where 3rd party app developers can develop and then publish Mini Programs within the Tinaba application. Users will be able to buy products, book services, and gain access to exclusive promotions and discounts inside the Tinaba app thanks to Alipay+ Mini Programs.

These are small 3rd party-developed mobile applications that eliminate the necessity to download several separate apps and promise to offer users a much more streamlined experience in Italy and 26 other countries across the globe. The integration will grant Tinaba users having Banca Profilo access the latest Mini Programs from different physical and digital touchpoints.

It has also provided third-party tech developers and merchants with access to a host of new opportunities by broadening their potential market. Alipay+ currently has more than 200,000 users of Tinaba having Banca Profilo globally and will provide a robust platform for merchants to develop and manage Mini Programs as trade and digitalization become increasingly entwined.

Online booking platform Tiqets will be the first Mini Program on Tinaba having Banca Profilo. The global booking platform allows users to buy tickets to more than 4,000 attractions and museums across the globe within the Tinaba app using a transparent and intuitive user interface. The Mini Program’s integration will significantly simplify the payment and planning process typically involved in booking tickets to such attractions.

With a single Alipay+ Mini Program offering this much utility, it is clear that integrating the technology into Tinaba powered by Banca Profilo will be a game-changer. Users will be able to use a wide array of different services without leaving the application as merchants and 3rd party developers develop and add more Mini Programs.

Alipay parent company Ant Group first partnered with Banca Profilo and Tinaba in 2016 and extended its Alipay+ solution to Tinaba alongside Banca Profilo users last year, allowing them to make mobile money payments at over 2.5 million Alipay+ supported stores across Europe. Thanks to the partnership between Ant Group and the two fintech firms, Tinaba users can now make mobile money cross-border payments in 27 countries with Alipay+ merchants.

Mobile connectivity is helping to expedite cross-border systems in aspects like social media and mobile payments. As entities like Momo Inc. (NASDAQ: MOMO) make further inroads into their chosen markets, it is likely that they too could enter into relationships like the one which has been worked out by Banco Profilo and Tinaba to expand mobile money payment in Europe.

Momo Inc. (MOMO), closed Monday's trading session at $7.08, up 2.7576%, on 565,683 volume. The average volume for the last 3 months is 545,834 and the stock's 52-week low/high is $4.79/$8.19.

Compass Pathways PLC (CMPS)

InvestorBrandNetwork, QualityStocks, InvestorPlace, MarketBeat, PsychedelicNewsWire, Daily Trade Alert, Top Pros' Top Picks, StreetInsider, Schaeffer's, Prism MarketView, Trades Of The Day and The Street reported earlier on Compass Pathways PLC (CMPS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A guidebook that may help military veterans explore psychedelic treatments as possible therapies for mental health conditions like post-traumatic stress disorder was recently published. The guide, dubbed The Veteran’s Guide to Psychedelics, was launched on October 22nd.

It was developed specifically for veterans by the Heroic Hearts Project, in partnership with Matt Zemon, an author and educator. Zemon explained that the guidebook would help veterans that had turned to psychedelics for healing by assisting them in making informed decisions and empowering them to reclaim control over their emotional and mental health.

The guide provides a holistic framework for individuals to prepare, maneuver, and integrate their experiences with the entheogenic substances. It includes customized exercises to help veterans, emotionally, physically, and mentally prepare for psychedelic treatment.

The guide also provides step-by-step insights into ceremonial and medical settings, helping ensure that veterans possess the tools required to navigate their psychedelic experiences. In addition, it includes safety protocols, journaling and expert guidance to empower individuals on their journeys.

Heroic Hearts Project founder, Jesse Gould, revealed that the guidebook summarizes years of experience and dedication focused on ensuring individuals possess the right support and knowledge to access these healing practices in an informed and responsible way.

This almost 300-page resource has received support from various thought leaders in the fields of psychedelic research, trauma recovery, and mental health. Multidisciplinary Association for Psychedelic Studies (MAPS) founder, Rick Doblin, stated that the guidebook helped pave the way for individuals who wanted to access these life-saving therapies.

Dr. Bessel van der Kolk also applauded the resource for affording veterans the guidance and knowledge required to responsibly engage with psychedelic treatments.

Rear Admiral Losey, a retired Navy SEAL, also voiced his support for the guidebook. In his statement, he noted that the resource responsibly laid out important information for those who were searching for a way back to their best.

This release comes as more and more veterans call for psychedelic-assisted therapy reform. A number of veterans’ organizations have already pushed for Congress to increase access to psychedelics as well as cannabis, citing the urgent need for new treatments for a range of mental health conditions.

Additionally, the Veterans Affairs department has acknowledged the increasing support for psychedelic drugs. Dr. Shereef Elnahal, the department’s Under Secretary for Health, stated earlier in the year that this was an unstoppable narrative.

States like California and Massachusetts are also considering measures that’d expand veterans’ access to these drugs.

The guidelines above may be a good stopgap measure, but a better solution entails having approved psychedelic treatments on the market. Entities like Compass Pathways PLC (NASDAQ: CMPS) are working to see that their development pipelines yield FDA-approved psychedelic medicines.

Compass Pathways PLC (CMPS), closed Monday's trading session at $6.36, up 1.2739%, on 851,749 volume. The average volume for the last 3 months is 909,081 and the stock's 52-week low/high is $5.01/$12.75.

Cronos Group Inc. (CRON)

InvestorPlace, Schaeffer's, QualityStocks, Kiplinger Today, MarketClub Analysis, StocksEarning, The Street, MarketBeat, Daily Trade Alert, Trades Of The Day, The Online Investor, Wealth Insider Alert, StockEarnings, Market Intelligence Center Alert, StockMarketWatch, StreetInsider, BUYINS.NET, The Wealth Report, Zacks, CannabisNewsWire, Investopedia, Top Pros' Top Picks, Stock Up Featured, Daily Profit, Cabot Wealth, InvestmentHouse, Jim Cramer, Early Bird, InsiderTrades, The Rich Investor, Money Morning, InvestorsUnderground, 24/7 Trader, TheTradingReport, VectorVest, Wall Street Window, Small Cap Firm, Stock Gumshoe and InvestorsObserver Team reported earlier on Cronos Group Inc. (CRON), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The Arkansas Supreme Court decided in a narrow 4-3 ruling that votes in favor of and against a plan to broaden the state’s medical cannabis program would not be taken into account. Protect Arkansas Kids, a nonprofit that joined the legal fight against the amendment—Issue 3, filed a case that resulted in this decision. The votes cast on Issue 3 will be ignored, even though it will still be on the ballot in November.

The amendment sought to introduce several modifications to the state’s medical cannabis system, which was initially approved in 2016. It sought to ease licensing rules, widen the range of qualifying illnesses and medical professionals authorized to prescribe cannabis as well as permit patients to grow their marijuana at home.

However, in its decision, the court rejected Secretary of State John Thurston’s initial complaint. The main argument of the complaint focused on paid canvassers’ training requirements. Thurston contended that the group supporting the proposal, Arkansans for Patient Access, did not reach the required 90,704 valid signatures to qualify for the ballot due to non-compliance with state laws related to canvassers’ training.

In his majority opinion, Justice Shawn Womack supported a second legal complaint that argued the proposal’s ballot title and popular name were inadequate. Justice Womack also objected to a clause in Issue 3 that would have permitted the holding of up to one ounce of cannabis if it were to be legalized federally. He argued that this provision was misleading, as it would apply even to those without a medical cannabis prescription, contradicting the popular name, which solely references medical cannabis.

Womack was joined in the majority opinion by Justices Bilenda Harris-Ritter, Barbara Womack Webb, and Don Curdie.

Meanwhile, Justices Cody Hiland, Rhonda Wood, and Karen Baker dissented from the majority ruling. Hiland contended that the initiative’s ballot title and popular name were neither insufficient nor misleading. He argued that the court’s long-standing legal standard for determining the sufficiency of ballot titles had been disregarded in this case and that voters should have been allowed to decide on the initiative.

Arkansans for Patient Access expressed disappointment over the court’s decision, calling it a setback for the state’s medical cannabis program. They reaffirmed their commitment to removing barriers for patients and reducing costs while accusing anti-cannabis politicians of ignoring the will of the people.

Conversely, Protect Arkansas Kids praised the ruling describing the ballot initiative as misleading. They claimed it was part of a broader effort by the cannabis industry to legalize potent, addictive drugs under the pretense of medicine.

The ruling is likely to be a disappointment to the broader cannabis industry, including firms from across the border like Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) since the issues that the ballot measure was seeking to address will persist until the next election cycle when campaigners can launch another attempt to enact change.

Cronos Group Inc. (CRON), closed Monday's trading session at $2.23, up 0.4504505%, on 518,042 volume. The average volume for the last 3 months is 9.464M and the stock's 52-week low/high is $1.72/$3.14.

Pinterest (PINS)

Schaeffer's, InvestorPlace, Kiplinger Today, StockEarnings, MarketClub Analysis, MarketBeat, The Street, Zacks, StocksEarning, Trades Of The Day, Daily Trade Alert, INO Market Report, The Online Investor, QualityStocks, Investopedia, Early Bird, Cabot Wealth, Top Pros' Top Picks, StreetInsider, Wealth Insider Alert, FreeRealTime, TipRanks, TradersPro, StockMarketWatch, StreetAuthority Daily, CNBC Breaking News, Investment House, BUYINS.NET, InvestmentHouse, InvestorsUnderground, Investing Daily, InsiderTrades, Market Intelligence Center Alert, Hit and Run Candle Sticks, Louis Navellier, 360 Wall Street, Rick Saddler, Smart Investing Society, Smart money trading, AllPennyStocks and Trading Tips reported earlier on Pinterest (PINS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Pinterest (NYSE: PINS) is a social media platform that allows users to discover and save ideas through images and videos. It competes with other social media giants like Facebook and Instagram. Currently, Pinterest is facing a significant privacy complaint in the European Union. The complaint, filed by the non-profit organization noyb, accuses Pinterest of violating the General Data Protection Regulation (“GDPR”) by not obtaining user consent for tracking and profiling for advertising purposes.

The GDPR is a strict privacy law in the EU that can impose penalties of up to 4% of a company’s global annual turnover for confirmed breaches. This could mean substantial financial consequences for Pinterest if the complaint is upheld. The complaint points out that Pinterest uses a legal basis called legitimate interest (“LI”) to process user data for ad targeting. However, noyb argues that this is not compliant with the GDPR, especially after a July 2023 ruling by the EU’s top court against Meta’s similar practices.

Pinterest has around 130 million users in the EU, and it tracks users by default for personalized ads. Users must actively opt-out to stop this tracking. Kleanthi Sardeli, a data protection lawyer at noyb, claims that Pinterest is “secretly tracking European users without asking for their consent,” which allows the platform to profit unlawfully from personal data. The complaint also mentions that Pinterest failed to fulfill a GDPR data access request, as the complainant did not receive information about data shared with third parties.

Noyb is urging Pinterest to delete any data processed for ads and inform users of this action. They are also advocating for a fine that would deter future GDPR breaches. The complaint has been filed with France’s data protection authority, CNIL, known for its strong enforcement on privacy complaints. However, due to the GDPR’s “one-stop-shop” mechanism, the case might be transferred to Ireland’s Data Protection Commission, as Pinterest’s regional headquarters are in Dublin.

To view the company’s most recent press release, visit https://ibn.fm/iKihI.

About Pinterest Inc.

Pinterest is a visual search and discovery platform where people find inspiration, curate ideas and shop products—all in a positive place online. Headquartered in San Francisco, Pinterest launched in 2010 and has over half a billion monthly active users worldwide. For more information, visit the company’s website at www.Pinterest.com.

Pinterest (PINS), closed Monday's trading session at $32.26, off by 0.2782071%, on 5,248,866 volume. The average volume for the last 3 months is 577,634 and the stock's 52-week low/high is $24.465/$45.185.

The QualityStocks Company Corner

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX)

The QualityStocks Daily Newsletter would like to spotlight McEwen Mining Inc. (NYSE: MUX) (TSX: MUX).

While it is common knowledge that investors in tech firms like Nvidia Corp. (NASDAQ: NVDA) are accumulating fortunes from AI, the island of Anguilla is also minting serious cash from this industry. This started at about the time ChatGPT went public and set off a frenzy among companies wishing to get websites ending in .ai. Cue in Anguilla. This British territory in the Caribbean didn't know it had struck future gold when, by a stroke of luck, it was allocated the .ai internet address back in 1995. Each country has a unique internet address for sites located within its jurisdiction, and Anguilla found itself with the .ai address for its internet traffic. It should be noted that it isn't compulsory for a website to contain the internet initials of the country where it is domiciled, but many still include that address as part of the website address. Demand for sites with this ending has skyrocketed to the extent that the government of Anguilla has contracted Identity Digital, an American-based firm also hired by Australia, to manage this domain registration and renewal process. The domains are so much in demand that some have been sold at multiples of $10,000! This island, which is famous for its premium tourist attractions (clear waters, coral reefs and white sand beaches teeming with palm trees) favored by the ultra-wealthy as a holiday destination, is using this uptick in revenue to expand the country's airport, provide free healthcare services to the elderly, and also complete a tech training institution on the island. Amidst the frenzy of the AI boom, much of the spotlight remains on tech giants and trailblazing innovators. Yet, underpinning this high-tech revolution are essential "workhorse metals"—silver, gold, and copper—that make the infrastructure for AI possible, from advanced graphics processors to expansive data centers. Companies like McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) that focus on mining these critical metals are positioned to benefit from AI's burgeoning demand. Just as fortunes were made by supplying shovels during the California Gold Rush, today's mining companies play a pivotal role by providing the foundational resources that fuel the AI industry.

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) is an asset rich diversified gold and silver producer in the Americas with a large exposure to copper through its subsidiary, McEwen Copper, owner of the Los Azules copper deposit in Argentina, believed to be the 8th largest undeveloped copper resource in the world.

Led by a management team with a track record of success, MUX owns and operates mines in some of the most prolific gold producing regions of the Americas. The company proactively took cost-saving measures months ago to lower expenses and increase production across its portfolio of gold assets, driving some production costs below industry averages. Gold and copper prices, already in an upswing, are forecast to enter an explosive uptrend over the next couple years. Drawing from its experience, McEwen Mining planned, prepared and laid the groundwork to capitalize on this emerging opportunity.

The company currently holds a Zacks Rank #1 (Strong Buy), placing it in the top 5% of over 4,000 stocks ranked by Zacks, based on trends in earnings estimate revisions and EPS surprises. Seldom is management so aligned with investors’ interests and committed to the company’s success. With a combined investment of over $220 million, CEO Rob McEwen holds a 17% ownership stake in McEwen Mining and a 13% ownership in McEwen Copper. Acclaimed in the mining industry, McEwen founded Goldcorp, where he increased the company’s market capitalization 160 times – from $50 million to over $8 billion. That same vision and tenacity led MUX in creating McEwen Copper.

For McEwen Mining shareholders, beyond the company’s exposure to gold upsurges, its 47.7% stake in McEwen Copper is expected to be a blockbuster, turbocharging MUX by creating the world’s next prolific copper unicorn.

McEwen Copper

With continuous industrial need, new critical demand for copper is rapidly emerging, increasingly driven by the green energy transition. The price of copper rose from a low of about $2 per pound in 2020 to over $4.60 per pound in May 2024, and strong demand is expected to intensify. A study by S&P Global, titled The Future of Copper: Will the Looming Supply Gap Short-circuit the Energy Transition?, projects global copper demand to nearly double over the next decade, from 25 million metric tons today to about 50 million metric tons by 2035. Based on current trends, S&P Global forecasts annual supply shortfalls to reach nearly 10 million metric tons in 2035.

McEwen Mining owns a 47.7% equity stake in McEwen Copper, the holder of a 100% interest in the Los Azules copper project in San Juan, Argentina, which is ranked the 8th largest undeveloped copper deposit in the world. Current copper resources at Los Azules are estimated at 10.9 billion pounds at a grade of 0.40% Cu (Indicated category) and an additional 26.7 billion pounds at a grade of 0.31% Cu (Inferred category). McEwen Copper also owns a copper exploration project in Nevada, USA, called Elder Creek.

In a 2023 Preliminary Economic Assessment (PEA), Los Azules was estimated to have a 27-year life, producing an average of 322 million lbs. of copper cathode annually, at a cash cost of $1.07 per lb. of copper, in the lowest quartile of the copper cost curve. The project could ultimately become an even larger mine with a longer life, since the extent of mineralization has not been fully assessed on the property.

The project’s 2023 PEA presents a distinctly different development strategy from a prior PEA published in 2017. By proposing a heap leach project using solvent extraction-electrowinning instead of the previously detailed mine with a conventional mill and flotation concentrator, McEwen Copper aims to decrease its environmental footprint and reduce permitting risk, albeit with a lower overall copper recovery, slightly higher unit costs and a delay in immediate cashflow due to extended leach cycles.

After securing a $25 million investment from mining giant Rio Tinto’s technology arm, Nuton LLC, McEwen Copper closed its non-brokered, private placement offering of $82 million in August 2022. Shortly after, in February 2023, Nuton agreed to invest an additional $30 million into McEwen Copper, and in October 2023, Nuton once again expanded its stake, investing an additional $10 million to bring its ownership position in McEwen Copper to 14.5%.

“We are extremely pleased to have Nuton’s strong continued participation in McEwen Copper,” Rob McEwen stated in a news release. “Together we are exploring new technologies that save energy, water, time and capital in the pursuit of delivering green copper to Argentina and the world, a product that will contribute to the electrification of transportation and the protection of our atmosphere.”

Also in February 2023, FCA Argentina S.A., a subsidiary of Stellantis N.V., one of the world’s leading automakers, invested ARS $30 billion in McEwen Copper. In October 2023, Stellantis invested an additional ARS $42 billion, bringing its current stake in McEwen Copper to 19.4%.

“We are delighted to have Stellantis as a partner in the future development of our Los Azules copper project,” Rob McEwen said of the investment. “Together, we share a vision to build a mine for the future based on regenerative principles that can achieve net-zero carbon emissions by 2038.”

Following the capital raise, McEwen Copper is well-funded to advance its Los Azules Project, with a Feasibility Study planned for Q1 2025. MUX strategically reduced its interest to increase its treasury, in order to reduce debt and fund the further development of its gold and silver assets.

Gold & Silver Projects

The Fox Complex

McEwen Mining owns a 100% stake in the Fox Complex in the heart of a prolific gold district in Timmins, Canada.

“When MUX bought the Fox Complex, in late 2017, it was a distressed asset with a history of high operating cost/oz. While it has taken longer than I expected, the cost to produce an ounce of gold is significantly lower,” CEO Rob McEwen stated in a news release.

McEwen Mining issued 2024 guidance for its cash cost/oz at the Fox Complex of $1,225-1,325 on annual production of 40,000-42,000 GEOs. Fox Complex produced 44,450 GEOs in 2023, which was within the company’s guidance range.

Located in one of the most prolific gold production areas in the world, along the Destor-Porcupine Fault Zone within the Abitibi Greenstone Belt, the Fox Complex includes the Black Fox mine and Froome mine which together have yielded over 1,000,000 ounces of gold to date. Also, the complex includes the Grey Fox and Stock deposits that have over 1,800,000 ounces in gold resources. The 2.7-billion-year-old Abitibi Greenstone Belt, formed by ancient volcanic activity, has proved to be one of the world’s richest and most abundant gold regions, with a total gold content currently estimated at over 300 million ounces.

In 2024, MUX commenced development of underground ramp access to the Stock orebodies at the Fox Complex. This development will become the primary source of feed following the completion of mining the Froome deposit in 2026. As part of the future mining sequence initiative, the company has already reported a 31% year-over-year increase of gold resources at Stock West and Stock Main (historical Stock Mine), with confirmation of good grading structures plunging to depth. It has also identified Stock East as a potential new near-term source of future revenue.

The Gold Bar Mine

McEwen Mining owns a 100% stake in the Gold Bar mine, located in an area well known for gold production, the southern Roberts Mountains of the Battle Mountain-Eureka-Cortez gold trend in Eureka County, Central Nevada. The Gold Bar mine is on the same geological structure, 25 miles south of Nevada Gold Mines, a Barrick-Newmont joint venture, part of the Cortez-Goldrush complex. This complex contains estimated reserves and resources of over 50 million gold ounces, with an annual production of 1,000,000 gold ounces.

Gold Bar had been mined between 1991 and 1994, producing 134,000 gold ounces. A new facility was built by MUX in 2019. Gold Bar accounted for 42,700 GEOs in 2023, within the company’s guidance for the year. For 2024, McEwen Mining issued guidance of 40,000-43,000 at a cash cost of $1,450-1,550. The first half of the year is expected to deliver higher production relative to the second half, due to a scheduled waste stripping phase in the Pick pit, in preparation for the 2025 mining program.

Notably, in April 2024, McEwen Mining announced its entry into a definitive agreement and plan of merger with Timberline Resources Corporation (TSX.V: TBR) (OTCQB: TLRS) in a transaction valued at roughly $18.8 million. The merger with Timberline is expected to augment McEwen’s existing portfolio of development and exploration projects in Nevada, leveraging synergies between Timberline’s projects and the Company’s Gold Bar mine.

El Gallo/Fenix

Project Fenix is the proposed redevelopment plan for McEwen Mining’s El Gallo Complex in Mexico. There is a long history of mining in this region. MUX began operating it as an open pit, heap leach mine in 2013, which produced 281,000 gold equivalent ounces at average cash cost of $655 per ounce. Due to the transition to deeper sulfide mineralization that is not amenable to heap leaching, mining activities ceased in the second quarter of 2018 and residual heap leaching followed until mid-2022. The redevelopment plan envisions constructing a mill at the existing mine site that will initially reprocess the existing heap leach material, then transition to open pit mining and processing of the sulphide mineralization. The company recently acquired a complete process plant on very advantageous terms that has considerably reduced the projected capital requirements for the project.

CEO Rob McEwen stated in a news release, “This acquisition has made Fenix more attractive to build and could provide a new long life mine for McEwen Mining.”

The initial development approach is to build a mill to reprocess the material on the heap leach pad and produce approximately 17,000 oz of gold annually for eight years. Construction of the Fenix project is expected to begin in the second half of 2024.

San José Mine

McEwen Mining is a 49% owner and non-operator of the San José gold and silver mine, located in Santa Cruz province, Argentina, encircling Newmont’s prolific Cerro Negro (approx. 300,000 gold ounces produced in 2023). This high-grade underground mine has been operating since 2007 and currently has an expected life of six years with a reserve grade of 296 gpt silver and 5.4 gpt gold.

Exploration is continuing to extend high-grade veins and discover new veins at the complex. San José’s drilling programs to define additional resources and reserves have a long history of success due to a high vein density, aided by good geophysical response from hidden veins.

Production guidance for 2024 for MUX’s 49% interest is 50,000-60,000 GEOs. As a minority shareholder in the mine, MUX equity accounts for its investment in San José, and receives 49% of the dividends from the mine’s free cash flow.

Market Outlook

Mining stocks suffered significant losses in the wake of the COVID-19 pandemic. However, this has turned, and many analysts now forecast a gold bull market in 2024 and beyond.

“The operating challenges we faced in recent years have severely damaged our credibility with our shareholders and the market. As a result, few investors have taken a close look recently at our assets,” Rob McEwen said in a news release. “If they did, I believe some would see the potential value that I see today… I believe there is considerable potential value in MUX, and that is a big reason why I have a personal financial commitment of $220 million in MUX and McEwen Copper.”

Management Team

Robert R. McEwen is Chairman, CEO and Chief Owner of McEwen Mining. He has been associated with the gold industry all his career, with his first 18 years in the investment industry and, since 1990, as CEO of several gold mining companies. He founded Goldcorp and took that company from a $50 million market capitalization to more than $8 billion. He owns 17% of McEwen Mining and is in complete alignment with investors – his investment in MUX and McEwen Copper is $220 million and he takes an annual salary of only $1. He was awarded the Order of Canada and the Queen Elizabeth’s Diamond Jubilee Award, was inducted into the Mining Hall of Fame, was named an Ernst and Young Entrepreneur of the Year and has Honorary Doctor of Law degrees from York University and Western University.

William Shaver is interim COO and a Director of McEwen Mining. He has decades of management and executive experience in mine design, construction and operations. He was a founder of Dynatec Corporation, which became one of the leading contracting and mine operating groups in North America. In 2013, he was recognized as Ernst and Young Entrepreneur of the Year. Most recently, he served as COO of INV Metals. He is a Professional Engineer with a B.Sc. in Mining Engineering from Queens University.

Perry Ing is interim CFO at McEwen Mining. He has 25 years of experience in the Canadian mining industry. Over the past 15 years, he has held positions as CFO of Mountain Province Diamonds, Kirkland Lake Gold and McEwen Mining. Prior to that, he worked at Barrick Gold and Goldcorp and started his career in the mining practice at PwC. He has a Bachelor of Commerce from the University of Toronto and is a Chartered Professional Accountant in Canada and Certified Professional Accountant in the U.S.

Adrian Blanco S. is the company’s Director of Operations for America and Mexico. He has extensive international experience in several industrial sectors and has held executive positions in Mexico, the United States, Peru and Argentina. He joined the McEwen Mining team in 2015 and has led a successful business transformation toward operational discipline, best business practices and financial profitability at subsidiaries Compañia Minera Pangea and McEwen Mining Nevada. He graduated from an Executive Management Program at IPADE and Harvard Business School.

Michael Meding is Vice President and General Manager of McEwen Copper. He has over 20 years of international experience, primarily with major mining companies such as Barrick Gold and Trafigura, including extensive experience with project development and operations in Argentina. While at Barrick Gold’s Veladero mine in Argentina, Mr. Meding played a key role in the turnaround, extension of the mine life and subsequent strategic partnering with Shandong Gold. He holds an MBA from Indiana University in Pennsylvania and an MBA from the Leipzig Graduate School of Management in Germany.

McEwen Mining Inc. (NYSE: MUX), closed Monday's trading session at $10.3, off by 0.7707129%, on 309,104 volume. The average volume for the last 3 months is 1.452M and the stock's 52-week low/high is $5.92/$12.50.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Energy ministers from the 9 nations dubbed the North Seas countries have reaffirmed their commitment to transforming the region into Europe's renewable energy hub. Speaking at the just-concluded North Seas Energy Cooperation (NSEC) ministerial meeting held in Odense, Denmark, the Energy Ministers gave the new Europe Commission recommendations on how it can support this goal. The recommendations particularly focused on the need to bolster the continent's supply chain for wind energy. Despite Europe's significant potential for offshore wind energy, most of its green energy capacity is generated from solar farms. The energy ministers also discussed the need to create new financing facilities for offshore wind and deploy hybrid offshore wind farms on a cost-sharing formula as soon as possible. Unfortunately, WindEurope noted, supply chain bottlenecks in port infrastructure, availability of service vessels, offshore wind installation, and skilled workers, as well as the reinforcement and expansion of offshore grid connections, remain. As this group of countries implements its green energy plans, electric vehicles like those commercialized by Mullen Automotive Inc. (NASDAQ: MULN) will be a great addition to their markets since these zero-emission vehicles can help in the attainment of the countries' net-zero goals.

Mullen Automotive (NASDAQ: MULN) announced that Bollinger Motors founder, Robert Bollinger, has provided $10 million in non-dilutive debt financing to accelerate the production and sales of Bollinger's all-electric Class 4 B4 truck. This funding supports Bollinger's full-scale production efforts, with trucks now assembled by Roush Industries in Michigan, using over 70% U.S.-made content. Mullen CEO David Michery commended Bollinger's continued commitment to building the brand, with more details on the financing to be filed in an upcoming Form 8-K with the SEC. To view the full press release, visit https://ibn.fm/HCNb4

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Monday's trading session at $2.53, off by 9.6429%, on 2,551,452 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $12.50/$.

Recent News

Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG)

The QualityStocks Daily Newsletter would like to spotlight Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG).

The Biden administration aims to weaken Russia's financial stability through sanctions, limiting its ability to sustain its war efforts in Ukraine.

Imposing sanctions on Russian titanium and palladium would create several strategic advantages for the U.S.

Sanctions on Russian palladium and titanium could be especially advantageous for existing producers and emerging palladium mining projects outside of Russia.

The United States recently called on its Group of Seven ("G7") allies to consider imposing sanctions on Russian titanium and palladium supplies, a move that, if approved, could have a profound impact on global metals markets as well as on Russia's economy (https://ibn.fm/Q9sHS). Companies operating in the metals sector, including Platinum Group Metals (NYSE American: PLG) (TSX: PTM), majority owner and operator of the Waterberg PGM Project in South Africa, are watching closely to see what action the G7 might take.

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) is the operator of the Waterberg Project, a bulk underground platinum group metals (PGM) deposit discovered by Platinum Group in 2011 and located on the Northern Limb of the Bushveld Complex in South Africa. The Waterberg Project is planned as a fully mechanised platinum, palladium, rhodium and gold mine, including by-product copper and nickel production, and is projected to be one of the largest and lowest cost PGM mines globally.

The project is a joint venture between Platinum Group; integrated PGM producer Impala Platinum Holdings Ltd. (OTCQX: IMPUY); Japanese consortium HJ Platinum, which includes trading house Hanwa Co. and the government-backed Japan Organization for Metals and Energy Security (JOGMEC); and local empowerment partner Mnombo Wethu Consultants (Pty) Ltd. Platinum Group has an effective 50.22% interest in the Waterberg Project.

The company’s primary business objective is to advance the Waterberg Project to a development and construction decision. An update to the 2019 Definite Feasibility Study is expected in 2024.

PGMs are essential and precious metals that include platinum, palladium, rhodium, iridium, osmium and ruthenium. These metals are known for their purity, high melting points and unique catalytic properties. They are utilized in a number of industrial processes, technologies and commercial applications and play a critical role in autocatalysis and pollution control in the automotive sector. The bulk of global PGMs are mined in Southern Africa and Russia.

The unique properties of PGMs are being applied to various technologies as possible solutions for more efficient energy generation and storage, which may create new demand for PGMs. The company’s battery technology initiative through Lion Battery Technologies Inc., using platinum and palladium in lithium battery technologies, represents one such new opportunity in the high-profile lithium battery research and innovation field.

Platinum Group Metals Ltd. founded Lion Battery Technologies Inc. in partnership with Anglo American Platinum Ltd. (AMS: JNB) to support the use of palladium and platinum in lithium battery applications. Lion Battery has entered into an agreement with Florida International University to further advance a research program that uses platinum and palladium to unlock the potential of Lithium Sulfur (Li-S) battery chemistries.

Platinum Group is headquartered in Vancouver, B.C., and Johannesburg, South Africa.

Waterberg Project

Platinum Group’s sole material mineral property, the Waterberg Project, is presently in process with pre-construction permitting; engineering work, including road upgrade and traffic studies; finalization of power and water infrastructure design; and construction camp design.

The company’s principal product from the Waterberg Project is planned to be a PGM-bearing concentrate. The concentrate will contain economic amounts of six elements comprising platinum, palladium, rhodium, gold, copper and nickel. The company’s partner in the Waterberg Project, Impala Platinum Holdings, has acquired a right of first refusal to enter into an offtake agreement, on commercial arm’s-length terms, for the smelting and refining of mineral products from the Waterberg Project.

The Waterberg project has proven and estimated reserves of 19.5 million ounces of PGMs and gold. When fully operational, the mine is projected to produce more than 400,000 ounces of PGMs annually during the peak period of steady state production. The life of the mine is projected at 45 years.

South Africa’s PGM mining sector remains closely tied to economic developments in the global automotive industry, which in 2022 accounted for approximately 43% of the total global demand for platinum and 82% of the total global demand for palladium.

Market Opportunity

According to a report from Straits Research, a global market and business research firm, the worldwide platinum market had an estimated value of $7.72 billion in 2022 and is projected to reach $11.95 billion by 2031. That represents a CAGR of 5.13% over the forecast period.

Platinum, one of the rarest of precious metals, is about 30 times scarcer than gold. It is crucial to the automotive and electronics industries and is also used to make jewelry. Stricter emissions regulations around the world have led to an increased demand for platinum to be used in catalytic converters to reduce automotive emission, the report states.

A report from Allied Market Research estimated the global palladium market at $16.3 billion in 2021 and projects the market will reach $28.6 billion by 2031, growing at a CAGR of 5.8% over the period.

Palladium is also used in automotive catalytic converters for reducing emissions and in jewelry, dentistry, watchmaking, blood sugar test strips, aircraft spark plugs, surgical instruments, electrical contacts and musical instruments.

An increase in demand for consumer electronics has driven demand for palladium-based multilayer ceramic capacitors (MLCC) used to store energy in electronic devices such as broadcasting equipment, mobile telephones, computers, electronic lighting and high voltage circuits, according to the report.

Management Team

Frank R. Hallam is Co-Founder, Director, President and CEO of Platinum Group. He has over 30 years of experience in the mining, minerals and petroleum industry as an operator, principal and founder. He was a co-founder and former CFO of MAG Silver Corp. He was also co-founder and director of West Timmins Mining Inc. and a director of Lake Shore Gold Corp. In addition, he was CFO and director with gold exploration company Tan Range Exploration Corp. He is a Chartered Professional Accountant and was formerly an auditor in the public mining practice of PwC. He holds a Bachelor of Business Administration from Simon Fraser University.

Greg Blair is CFO of Platinum Group. He has been with Platinum Group since 2010 in various roles, most recently as Interim CFO. Prior to joining Platinum Group, he was at a public accounting firm working on public company (mainly mining) audits. He is a Chartered Professional Accountant and holds a degree in Economics from Simon Fraser University and has completed the Canadian Securities Course.

Kris Begic is VP Corporate Development of Platinum Group. He has over 25 years of experience in the mining industry and capital markets and has been involved with the raising of over $500 million for various exploration and development projects globally. His efforts are focused on project generation, mergers and acquisitions, capital markets, investor relations and marketing.

Platinum Group Metals Ltd. (NYSE American: PLG), closed Monday's trading session at $2.05, off by 6.3927%, on 960,002 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.942/$2.27.

Recent News

Brera Holdings PLC (NASDAQ: BREA)

The QualityStocks Daily Newsletter would like to spotlight Brera Holdings PLC(NASDAQ: BREA).

Brera Holdings (NASDAQ: BREA), a publicly traded multi-club soccer ownership company, spotlighted the evolving landscape of sports ownership, where increased capital inflow from private equity, sovereign wealth funds, and high-net-worth individuals is driving growth. Citing a Goldman Sachs report, Brera emphasized the rising influence of multi-club ownership organizations like City Football Group and RedBird Capital, which leverage commercial and player-trading synergies. CEO Pierre Galoppi noted that growing private equity and corporate investments allow clubs to enter competitive leagues, enhancing revenue and valuation. As sports modernize, opportunities are expanding across media rights, stadium enhancements, apparel, and digital content, creating a dynamic, high-potential landscape for investors.

To view the full press release, visit https://ibn.fm/Nqrzm

Brera Holdings PLC (NASDAQ: BREA) is an Ireland-based, international holding company focused on expanding its global portfolio of men’s and women’s sports clubs through a multi-club ownership approach. The company capitalizes on opportunities to earn tournament prizes, secure sponsorships, collect transfer fees, provide professional sports consulting services, and enhance the valuation of its clubs.

Brera Holdings builds on the legacy of Brera FC, an international football club (referred to as soccer in the U.S.), that it acquired in July 2022. Established in 2000 and based in Milan, Italy, Brera FC has distinguished itself by cultivating an alternative football legacy. In October 2024, the Internet Marketing Association awarded Brera FC with the Social Impact Through Soccer accolade at its IMPACT 5050 Conference, recognizing the club’s global perspective and positive contributions to society.

The company’s growth strategy focuses on unlocking value from undervalued sports clubs and talent, driving innovation, and generating socially impactful outcomes. Brera Holdings is actively expanding its Global Sports Group, acquiring professional football and other sports clubs in emerging markets such as Africa, Asia, and Europe.

By targeting top-division teams in less mainstream markets, Brera Holdings aims to strengthen its competitive position in regional tournaments, including those organized by the Union of European Football Associations (UEFA). These acquisitions are expected to enhance sponsorship revenues and create new growth opportunities.

Leveraging its expertise in capital raising and revenue generation, Brera Holdings also anticipates growing demand for its consulting services, providing advisory support to sports clubs, associations, investors, and others. Brera Holdings is headquartered in Dublin, Ireland, with additional offices in Milan, Italy.

Sporting Assets

Brera Holdings continues to grow its global sports portfolio with a series of strategic acquisitions and innovations, including the FENIX Trophy Tournament, a pan-European, non-professional football competition. Launched in September 2021 and organized by Brera FC, the tournament has been recognized by UEFA and described by BBC Sport as “the Champions League for amateurs.” In 2023, Brera FC hosted the tournament’s finals at Milan’s iconic San Siro Stadium.

In March 2023, Brera Holdings expanded into Africa by establishing Brera Tchumene FC in Mozambique. Starting in the country’s Second Division League, the team quickly earned promotion to Moçambola, Mozambique’s First Division League, by November 2023.

In April 2023, Brera Holdings further strengthened its European presence by acquiring a 90% stake in Fudbalski Klub Akademija Pandev, a first-division football team in North Macedonia. This acquisition provides access to two major UEFA competitions, solidifying the company’s position in European football.

Brera Holdings’ reach extends beyond football. In July 2023, it acquired majority ownership of UYBA Volley, an Italian Serie A1 women’s professional volleyball team, demonstrating its commitment to diversifying within top-tier sports.

In September 2023, Brera Holdings entered the Mongolian football market by acquiring Bayanzurkh Sporting Ilch FC, a Mongolian National Premier League team. For the 2024 season, the club was rebranded as Brera Ilch FC, further expanding Brera’s global footprint.

In January 2024, Brera Holdings initiated a proactive search for an Italian Serie B football club, aligning with its goal of bringing multi-club ownership opportunities to mass investors through its Nasdaq-listed shares.

In February 2024, the Brera Holdings Advisory Board was established with MLS founder and World Cup director Alan Rothenberg, luxury lifestyle executive Massimo Ferragamo, sports business leaders Paul Tosetti and Marshall Geller, and Italian football icon Giuseppe Rossi.

In June 2024, the North Macedonian women’s football club Tiverija Strumica officially became part of the Brera family with the establishment of a joint-stock company controlled by Brera Holdings called Women’s Football Club Tiverija Brera AD Strumica (“Brera Tiverija”). Brera Tiverija is now a wholly-owned subsidiary of Brera Strumica FC.

In September 2024 Brera announced that it signed an exclusive letter of intent to acquire an Italian Serie B club (the “LOI” and the “Club”). According to a CFA report published in June 2024, this expected strategic transaction, for an estimated purchase price of $21.6 million, would add first-year annual revenue of $10.8 million to Brera, and that revenue would likely increase by 25% each year for the next three years. The company’s capital valuation, projected the report, would also experience significant appreciation during this period.

In October 2024, Brera was recognized with the 2024 Social Impact Through Soccer Award at IMPACT 5050, an annual event honoring leaders and innovators who significantly impact their industries and communities. This is the second time Brera has won the award.

Market Opportunity

A report from IMARC Group, a global management consulting firm, reveals that the international football market generated approximately $3.3 billion in revenue in 2023, with projections to grow to $4.6 billion by 2032, reflecting a compound annual growth rate (CAGR) of 3.6%. Key drivers behind this growth include advancements in digitization, increasing sponsorship and partnership deals between brands and clubs, the rising interest in women’s professional soccer leagues, and the expansion of the e-sports and gaming sector.

In particular, Serie B Italian football clubs seem to present exceptionally attractive investment opportunities. As of September 2024, more than half of these clubs had appreciated between 80-100% in total market value, post-purchase.

As the world’s most-watched and most-played sport, soccer drives significant demand for football-related products and services, contributing to market growth. Broadcasting rights, sponsorships, and endorsement deals are also major revenue sources for clubs and organizations, with an expanding global fanbase generating new opportunities for financial growth, according to the report.

Management Team

With extensive experience in leadership and finance, Daniel McClory currently serves as the Executive Chairman and Director of Brera Holdings, PLC. He co-founded and held the position of Chief Executive Officer at Boustead & Company Limited, and previously served as the Managing Director, Head of Equity Capital Markets, and Head of China at Boustead Securities, LLC. Mr. McClory’s governance experience includes being a Board Director for USA Track & Field and a member of the Eastern Michigan University Champions Advisory Board. Mr. McClory’s expertise encompasses founding and financing equity capital markets, as well as navigating merger and acquisition transactions and initial public offerings. He holds a BS and MS from Eastern Michigan University, where he also received an honorary Doctor of Public Service. In addition to his professional qualifications, he is fluent in both English and Italian.

Pierre Galoppi serves as the CEO, Interim CFO, and director of Brera Holdings. With over 30 years of experience in strategic business and financial services, his career spans a variety of industries, including natural resources, aviation, cybersecurity, telecommunications, tourism, and international marketing. He has worked extensively across Latin America, the Caribbean, Canada, Europe, and the United States. Mr. Galoppi holds dual citizenship in Canada and Italy and is fluent in English, Spanish, Portuguese, Italian, and French. He earned a Bachelor of Commerce degree and an MBA from Concordia University in Montreal.

Maria Xing serves as the Head of Investments and Corporate Development. She is an executive who has specialized in MCO football (soccer) group investments for 777 Partners, where she was involved in sourcing, direct negotiations, due diligence, and closing deals, including acquiring a controlling stake in Brazilian Serie A football club, Vasco da Gama, and investing in Australian Premier League (“A-League”) side, Melbourne Victory FC. She also played a role in other professional sports franchise portfolio management, including topflight professional football clubs in Italy, France, Germany, and Belgium. Her background is in private equity, investment banking, and finance, with prior experience at The Raine Group, Credit Suisse, and EY (Ernst & Young), as well as previous sports industry experience at Liverpool Football Club in international business development. Ms. Xing earned an MBA from the Wharton School of the University of Pennsylvania and a B.S. from the New York University, Stern School of Business.

Additional Resources

Brera Holdings PLC (NASDAQ: BREA), closed Monday's trading session at $0.92, off by 1.0699%, on 149,008 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.5111/$3.00.

Recent News

Software Effective Solutions Corp. (OTC: SFWJ)

The QualityStocks Daily Newsletter would like to spotlight Software Effective Solutions Corp. (OTC: SFWJ).

Texas' Compassionate Use Program may be facing its worst crisis since its establishment in 2015. The program imposes strict rules on individuals with certain medical conditions who are eligible to use THC, what products can be sold to individuals, and where these products can be stored. These regulations have limited the impact of the program as well as its growth, while allowing unregulated hemp products like delta-9 and delta-8 THC to record increases in demand because they're easy to access. This has resulted in competition between the hemp industry and medical marijuana market in the state of Texas. It is important to note that delta-8 is still legal to sell and buy while the case is pending. Currently, it is legal to use and purchase most smokable hemp products like vape cartridges and flower with delta-8, THCA and CBD. How to regulate hemp products has become a major source of contention in many states and enterprises like Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) would be happier if this matter is resolved once and for all through Congressional action.

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) is a global infrastructure and holding company in the cannabis industry. MedCana currently has five companies focused on pharmaceutical cannabis production, as well a software company focused on managing processes for plant-to-patient operations. The recent acquisition of an irrigation and greenhouse technology company has rounded out MedCana’s portfolio of holdings.

MedCana’s focus is on developing clients and companies in Latin America, initially in Colombia, and partnerships with laboratories, research facilities and hospitals throughout the world. MedCana is building the technology, laboratories, growing facilities and scientific teams to provide premium pharmaceutical-grade cannabis extracts to the world.

MedCana’s goal is to be the world’s premier resource for pharmaceutical cannabis products. The company believes its advantage is its global view and reach. From initial cultivation to final product, MedCana aims to help partners produce pharmaceutical CBD and other extracts that will have no equal.

The company’s mission is to utilize its technology to partner with and develop companies that provide premium pharmaceutical-grade cannabis extracts with absolute integrity, sustainability and social responsibility. MedCana’s team of pharmaceutical scientists includes some of the most respected chemists in the world. They aim to ensure that the company’s customers and partners create premium cannabis extracts that meet the growing worldwide demand. MedCana’s software is designed to ensure traceability and quality from seed to finished product.

MedCana is headquartered in Austin, Texas, with offices in Colombia.

Production

MedCana announced in May 2023 the beginning of full-scale production of non-THC cannabis for export to Europe in response to high demand in that market. This expansion comes after the successful completion of full crop cycle testing and infrastructure development at production sites in Columbia.

The recent acquisition of the assets of Tokan Corp., a software company focused on creating an enterprise resource planning (ERP) platform for the cannabis industry, and Eko2O S.A.S., a greenhouse and irrigation engineering company, has positioned MedCana for explosive growth in the region.

As a MedCana subsidiary, Eko2O SA will increase the company’s revenue potential in Central and South America. The subsidiary specializes in the construction and distribution of greenhouses and sophisticated irrigation platforms. A positive outlook has resulted from the company’s expansion as it investigates new opportunities for greenhouse and irrigation system installations in Panama and Uruguay. These opportunities are expected to accelerate Eko2O’s development and strengthen its position as a top supplier of innovative agricultural solutions in cannabis and other sectors that are quickly moving to high technology agricultural production.

In addition, MedCana has started talks with the government in Argentina about possible incentives for beginning operations in that country as part of its ongoing worldwide development strategy. Support from the Argentinean government and the start of new operations there would greatly increase MedCana’s market share in Latin America and solidify the company’s position as the market leader in the cannabis industry.

Market Opportunity

According to a report by Grand View Research, a San Francisco-based market research and consulting company, the global cannabis extract market was valued at $3.5 billion in 2022 and is expected to expand at a CAGR of 20% from 2023 to 2030 to be worth more than $15 billion.

Growing demand for cannabis extracts, including oils and tinctures, and the increased legalization of marijuana for the treatment of different chronic ailments like arthritis, Alzheimer’s, anxiety and cancer are driving the expansion of the industry. The marijuana derivative industry is flourishing due to a greater understanding of its various medical benefits.

Management Team

Jose Gabriel Diaz is CEO of MedCana. He has successfully built, grown and sold multiple telecom companies. He was senior vice president of sales at IP Communications, a national high-speed data provider. He also founded Reallinx, a national data carrier later sold to GTT Communications. Additionally, he is currently president of the A.E.M. Business and Entrepreneurship Association in Austin, Texas.

Claudio Jiménez Cartagena, QF, Ph.D. is Chief Scientific Officer at MedCana. He joined MedCana after working with Sosteli Pharma as Technical Director and serving as a director consultant for the Corporation for Agricultural Industrial Development at the University of Antioquia in Colombia. Before that, he worked as the scientific director at the Institute of Food Science & Technology. He holds a bachelor’s degree in pharmaceutical chemistry, a master’s degree in basic biomedical sciences and a doctoral degree in Environmental Engineering from the University of Antioquia.

Julián Alberto Londoño Londoño, Ph.D., is Senior Vice President of Operations at MedCana. He previously served as general manager for the Corporation for Agricultural Industrial Development, and as Chief Scientific Officer at Sosteli Pharma in the Resource Management Department. He has developed multiple U.S. patents, and recently served as senior advisor to the Secretariat of Agriculture Development for the Government of Antioquia. He holds a doctorate in Chemical Sciences from the University of Antioquia.

Software Effective Solutions Corp. (OTC: SFWJ), closed Monday's trading session at $0.032, even for the day, on 35 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.000001/$0.09.

Recent News

Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF)

The QualityStocks Daily Newsletter would like to spotlight Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF).

Annovis Bio Inc. Overview

Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) is an active mineral exploration company engaged in the exploration and development of the company’s wholly owned multi-commodity mineral properties in Canada. The company owns the Parbec gold deposit on the Cadillac Break in Quebec and is currently exploring the Parbec property to increase the gold resource and identify a location to strip and bulk sample from surface.

In addition, the company holds the Nixon Bartleman gold property in Ontario and is also engaged in developing its wholly owned Malartic Metals Package, Quebec’s newest polymetallic battery minerals district with several areas of mineralization, one of which is the nickel, cobalt, copper and zinc mineralized Victoria structure boasting approximately 20 kilometers of strike with surface mineralization, limited drilling, road access and hydroelectric power.

Renforth is well positioned in the heart of the Abitibi Greenstone belt, which straddles the Canadian Provinces of Ontario and Quebec, on both of the Cadillac-Larder Lake and Destor-Porcupine faults – the two main structures responsible for a belt endowed with more than 300 million ounces of gold (including production, M&I reserves and resources to date), making it one of the world’s most prospective gold regions.

The Canadian Malartic Mine, one of Canada’s largest gold mines, is adjacent to each of Renforth’s brownfield Malartic area properties, the Parbec open pit gold resource and the Malartic Metals Package, which, in addition to several known battery metals mineralized structures, also hosts gold within the Pontiac sediments, a very under-explored geological setting.

The company is headquartered in Pickering, Ontario.

Projects

Parbec Gold Deposit

Renforth’s 100% owned Parbec Gold Deposit contains a gold resource designed with an open pit to capitalize on Parbec’s surface mineralization. An MRE on the project, effective December 2019 and now considered by Renforth to be obsolete, is based upon approximately 28,000 meters of drilling which occurred between 2007 and 2019.

Renforth drilled 15,000 meters of new holes in 2020 and 2021 which were not included in the MRE, but which did extend the mineralization deeper within the MRE. The 2020-21 drilling is considered to have validated an additional 13,000 meters of historic drilling from 1986-93.

The validation occurs as 10% of the historic holes were redrilled, with results comparable to the historic results in terms of geology and gold values. Any future MRE calculated at Parbec will benefit from the inclusion of the new and historic drilling.

In addition to this, Renforth’s current structural interpretation on the location of, and controls on, the gold mineralization at Parbec is materially different than the geological model for the outdated MRE. For the first time, Renforth has mapped the Pontiac contact and interpreted a hinge fold interacting with the Cadillac Break and allowing the movement of gold enriched fluids, with mineralization plunging to the south, into the Pontiac.

It is worth noting that a structural control on the adjacent, and much larger, Canadian Malartic Mine is the Sladen Fault transiting into the Pontiac. Currently, Renforth is testing this interpretation with a soil survey designed to outline an area for stripping and bulk sampling within the Pontiac south of the Cadillac Break.

Malartic Metals Package

Renforth’s wholly owned approximately 300-square-kilometer Malartic Metals Package in Quebec’s mining heartland includes surface mineralization of battery metals nickel, cobalt, copper, zinc and silver in separate structures, as well as a copper/silver discovery and gold mineralization. Lithium is also present in anomalous amounts in the sediments, though the source has not yet been located.

The property was assembled commencing in 2020 by adding claims to Renforth’s existing Malartic West property by map staking. The goal was to acquire historic gold and base metal showings, as well as pronounced magnetic anomalies, joining several of the areas of discrete historic exploration into a district scale property with several areas of interest for battery metals and a greenfield copper/silver discovery. The property benefits from its location in an established mining community, roads on the property, rail just off the property and hydroelectric power lines crossing the property, making logistics simple and the cost to operate quite low.

This is the first time this property has been assembled as it is today and actively explored. A significant portion of the property has never been explored.

Market Overview

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion. The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth.

This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council. In August 2024, the market price of gold was approximately $2,435 per ounce.

Management Team

Nicole Brewster is President and CEO of Renforth Resources. During her tenure she has reconstituted the company, developed a maiden mineral resource and sold a gold deposit. She is a native of the Toronto area and has been around the mining business nearly all her life, having been raised by a successful mineral exploration geologist who worked (and is still working) around the world as an entrepreneur and geoscientist.

Ms. Brewster worked summer jobs in various segments of the mining business, which led to her employment as a contractor working in the early days of the digitization of exploration data, 3D modeling and data visualization. After working in the capital markets for a time, she returned to the mineral exploration business as a partner in a successful private firm with several employees.

Renforth Resources Inc. (OTCQB: RFHRF), closed Monday's trading session at $0.0135, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0068/$0.0242.

Recent News

Nightfood Holdings Inc. (OTCQB: NGTF)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings Inc. (OTCQB: NGTF).

Nightfood Holdings Inc. (OTCQB: NGTF) is a visionary holding company focused on identifying and capitalizing on explosive market trends within hospitality, food services and consumer packaged goods. By leading newly emerging categories and seizing opportunities in markets undergoing transformational upheaval, the company’s mission is to create unparalleled upside potential in industries ripe for innovation and growth.

Subsidiaries

Nightfood Inc.

The company’s flagship subsidiary, Nightfood Inc., is changing the way the world snacks at night. Humans are biologically hard-wired to crave sweets and fats at night – a survival mechanism from our hunter-gatherer days. Modern consumers know bingeing excess calories before the long nightly fast is no longer necessary for survival, but exploding screen time and decreased willpower at night results in over 90% of American adults snacking between dinner and bed every week, contributing to an estimated one billion nighttime snack occasions weekly (according to SleepFoundation.org).

The most popular choices – ice cream, cookies, chips and candy – are not only unhealthy but also impair sleep quality due to their nutritional profiles. Nightfood snacks are uniquely formulated by sleep and nutrition experts to satisfy nighttime cravings AND support better sleep.

Market Opportunity

Euromonitor International projects the American snack market will grow from $150 billion in 2022 to $170 billion in 2027. Snacking between dinner and bed is estimated to account for over $60 billion annually, creating an opportunity for a multi-billion-dollar sub-category to emerge in the coming years: sleep-friendly snacking.

Nightfood is the brand pioneering that category.

Nightfood’s innovation has led to partnership overtures from global giants, including the largest food and beverage company in the world, Nestlé, with whom Nightfood completed a “test-and-learn” joint initiative in 2023.

Management believes that successfully scaling Nightfood’s 2024 direct-to-consumer launch of sleep-friendly cookies will bring the category to life, opening the door for partnerships with and potential acquisition by global snack giants seeking to lead this potential billion-dollar emerging sub-category.

Future Hospitality Ventures Holdings Inc. (d/b/a roboOp365)

Future Hospitality Ventures Holdings, operating under the brand roboOp365, is revolutionizing the hospitality industry with cutting-edge automation and robotic solutions.

roboOp365 enhances operational efficiency and guest experiences through innovative technologies, including automated culinary bot, server robots and AI-enhanced applications. roboOp365 helps hospitality providers reduce costs, streamline operations and deliver superior service by integrating these advancements.

Market Opportunity

The robots-as-a-service (RaaS) business model has gained significant traction, super-charged by the COVID-19 pandemic, which instantly catalyzed game-changing growth and application. According to Verified Market Research, the service robotics market is projected to reach $173.17 billion by 2030, growing at a compound annual growth rate (CAGR) of 21.25%. Compared to Asia, the United States market is in the early stages of adopting these technologies, but acceptance is accelerating aggressively.

Several factors are driving this trend. Key industries such as hotels and restaurants are still struggling to rebound from the pandemic’s impact, hoping to return to pre-pandemic levels, if possible. Such recovery will largely be dependent upon service robots. In California specifically, factors such as rising labor costs, more rigorous labor laws and ongoing high turnover rates in labor-intensive sectors make it impossible for businesses to survive, thrive and compete without robotics.

Innovation Across Sectors

Nightfood Holdings Inc. is dedicated to driving innovation across its focus sectors of food services, automation and hospitality applications. In food services, the company leverages automation technology to drive operational efficiency for operators while meeting evolving consumer needs. In the hospitality industry, it’s deploying solutions that redefine guest experiences. Nightfood’s consumer-packaged goods initiatives are key to breakthrough trends in health and wellness.

Synergizing Food and Technology

The synergy of food and technology within Nightfood Holdings Inc. creates a holistic approach to innovation and automation. By integrating these areas, the company offers comprehensive solutions that address multiple facets of market needs. Its automation and artificial intelligence solutions in food service and hospitality create a seamless and enhanced consumer experience.

Through this integrated approach, Nightfood Holdings Inc. not only meets current market demands but also anticipates and influences future trends, positioning itself as a leader in innovation across these interconnected sectors. Synergies in these related and explosive categories result in operational efficiency and benefits for the company’s customers and partners and outsized upside and opportunity for its investors.

Management Team

Sean Folkson is the Chairman and President of Nightfood. He founded Nightfood when he couldn’t find a solution to his nighttime snacking problem. Recognizing the growing body of research linking nutritional intake with sleep quality, he launched the first snack brand specifically formulated to give consumers better, healthier and more sleep-friendly snacks for that peak-cravings slot between dinner and bed. He is a serial entrepreneur and problem-solver, having previously founded Specialty Equipment Direct, an online distributor of floor removal equipment, and AffiliatePros.com, a pioneering company in online affiliate marketing.

Lei Sonny Wang is the CEO of Nightfood Holdings. He is a strategist and business driver for early-stage and growth-stage companies. He is the founder and former CEO of Future Hospitality Ventures Holdings Inc., which was acquired by Nightfood Holdings Inc. At Future Hospitality, he leveraged his significant international business development experience into distribution relationships with leading global robotics manufacturers. At Nightfood, he is working to grow revenue and improve performance and profitability across all subsidiaries.

Nightfood Holdings Inc. (OTCQB: NGTF), closed Monday's trading session at $0.014, up 12.9944%, on 362,300 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0075/$0.035.

Recent News

Clene Inc. (NASDAQ: CLNN)

The QualityStocks Daily Newsletter would like to spotlight Clene Inc. (NASDAQ: CLNN).

Clene Inc. (NASDAQ: CLNN) is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple sclerosis (MS).

Its lead drug candidate is CNM-Au8®, an oral suspension developed to restore neuronal health and function by increasing energy production and utilization by driving critical cellular energy producing reactions that enable neuroprotection and remyelination to increase neuronal and glial resilience to disease-relevant stressors. CNM-Au8 is being studied in various clinical trials, including the Harvard/MGH Healey ALS Platform clinical trial for patients with ALS; RESCUE-ALS, a completed proof-of-concept clinical trial in patients with early symptomatic ALS; the REPAIR trials, completed target engagement clinical trials showing brain energy metabolite change with CNM-Au8; and a completed MS clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing MS. The company also has a nanotherapeutic platform of drug discovery.

CNM-Au8

CNM-Au8, Clene’s lead asset, is a highly concentrated aqueous suspension of catalytically active, clean-surfaced, faceted gold nanocrystals. Multiple pathogenic insults contribute to neuronal death. Mitochondrial dysfunction and NAD+ decline is a common final pathway in neurodegeneration, with NAD+ as a critical determinant of cell survival and function. CNM-Au8’s catalytic mechanisms target the energetic deficits, oxidative stress and accumulation of misfolded proteins that are common to many neurodegenerative diseases.

The unique catalytic mechanism of action of CNM-Au8 is hypothesized to act as a neuroprotective and remyelinating therapy in neurodegenerative disease states in order to: (1) drive, support and maintain beneficial metabolic and energetic cellular reactions within diseased, stressed and/or damaged cells, (2) directly catalyze the reduction of harmful, reactive oxygen species (“ROS”) and (3) promote protein homeostasis via activation of the heat shock factor-1 pathway, recognized to dampen the cytotoxicity caused by misfolded and denatured proteins, which are known to occur ubiquitously in neurodegenerative diseases.

CNM-Au8 is used in combination with other agents, has no known drug-drug interactions, and is designed to improve function and survival. The clinical effects of both function and survival were seen in its clinical ALS trials, as earlier announced.

More than 500 estimated years of collective exposure across ALS, MS, and Parkinson’s disease participants in CNM-Au8 clinical trials and Expanded Access Protocol (compassionate use) programs have been recorded without any observed safety signals.

CNM-Au8 is a federally registered trademark of Clene Inc. Clene, based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland, began in 2013.

Market Opportunity

ALS is the most prevalent adult-onset progressive motor neuron disease, affecting approximately 30,000 people in the U.S. and an estimated 500,000 people worldwide, with a life expectancy of typically three to five years. Clene estimates that global ALS treatment sales will be greater than $1 billion annually within the coming few years. Additional treatments affecting daily function and survival remain the market need.

Additionally, there are more than 2 million MS patients globally, and Clene estimates the market size to be worth more than $23 billion annually. While the MS community has been successful at limiting relapses, non-relapsing MS patients continue to clinically deteriorate even while receiving effective immunomodulatory disease-modifying therapies (“DMTs”). A critical unmet medical need remains for therapeutic interventions that protect neuronal function and myelin health independent of immunomodulation to address progression independent of relapse activity.

Management Team

Robert Etherington is President, Director and CEO of Clene. He has more than 30 years of sales, marketing and leadership experience in the pharmaceutical industry. Prior to joining Clene, he worked at Actelion Pharmaceuticals, the largest biopharma company in the European Union prior to its acquisition by Johnson & Johnson in 2017, where he led that company’s U.S. commercial operations. He began his pharmaceutical sales and marketing career at Parke-Davis, a division of Pfizer, where he rose to the position of Team Leader overseeing the drug Lipitor.

Mark Mortenson is Chief Science Officer at Clene. He is co-inventor of the technology platform developed to produce the company’s therapeutics. He is the inventor or co-inventor on 32 other U.S. patents and hundreds of corresponding international patents. He is a former chief patent counsel responsible for 5,500 U.S. and international patents and patent applications. He holds bachelor’s degrees in physics and ceramic engineering from Alfred University, a master’s degree in materials science from Penn State University and a J.D. from George Washington University.

Benjamin Greenberg, M.D., MHS, FAAN, is Head of Medical at Clene. He is an internationally recognized expert in disorders of the central nervous system. He is currently professor of neurology and Vice Chair of Clinical and Translational Research in the department of Neurology at University of Texas Southwestern Medical Center in Dallas. He holds a bachelor’s degree from Johns Hopkins, a master’s degree in molecular microbiology and immunology from the Johns Hopkins School of Public Health and graduated from Baylor College of Medicine. He served residency in neurology at The Johns Hopkins Hospital.

Morgan R. Brown is CFO at Clene. He has more than 30 years of finance and accounting experience, with 23 years at biotech, pharmaceutical and medical device companies. He has served in similar roles at Lipocine Inc., Innovus Pharmaceuticals, World Heart Corp., Lifetree Clinical Research and NPS Pharmaceuticals Inc. He previously worked at accounting firm KPMG. He is a CPA with a bachelor’s degree in accounting from Utah State University and an M.S. in business administration from the University of Utah.

Clene Inc. (NASDAQ: CLNN), closed Monday's trading session at $5.87, up 9.7196%, on 75,145 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $3.8181/$12.00.

Recent News

Bebuzee Inc. (OTC: BBUZ)

The QualityStocks Daily Newsletter would like to spotlightFathom Bebuzee Inc. (OTC: BBUZ) .

Bebuzee Inc. (OTC: BBUZ), formerly Engage Mobility Inc., is a social platform and streaming service focused on development and deployment of America’s first superapp. The superapp will allow members to watch a wide variety of content, such as movies, series, documentaries and talk shows, on any internet-connected device.

Bebuzee’s technology scans the world’s news, features and information-flow to give its dedicated readers the best of the internet in one place – a one-stop platform for breaking news, interesting and important blogs, videos and photos.

The core features of the superapp include video streaming; photo sharing; Bebuzee Messaging service, which allows users to send text and voice messages and make voice and video calls; Shortbuz, used to make a variety of short-form entertaining videos; Blogbuz, a resource for people without time to scavenge the internet and other sources for news and information; Properbuz global real estate search; global tradesmen search; location reviews of neighborhoods, cities and even regions to help others find their ideal rental or real estate purchase; ShoppingBuz, a unique technology-driven e-commerce platform which gives merchants incredible tools to sell their products; Bebuzee Pay, a mobile payment and digital wallet service that allows users to make mobile payments and online transactions; TravelBuz, an online travel booking service; EventBuz, a ticket exchange and resale platform; and FlightBuz, a flight search engine.

The company is headquartered in Miami.

Introducing the Superapp to Western Markets

A superapp is a mobile phone app that offers a wide range of services within a single platform. This technology allows users to access various services without downloading and switching between multiple apps.

While superapps are popular in many parts of the world, including Latin America, Africa, the Middle East, Asia and Russia, they have achieved little adoption in Western markets. Perhaps the most widely known superapp is WeChat, which is estimated to have as many as 1.24 billion users, mostly in China.

Bebuzee aims to be the first developer to introduce and grow to widespread popularity a superapp in the U.S. and Europe. It took a strong step toward achieving this goal during the COVID-19 pandemic, when Bebuzee’s user base surged by 78% with over 42 million new users.

Whereas most social platforms are generic and only local postings make them somewhat relevant to local communities, Bebuzee has localized its platform for most countries by providing local content, entertainment and information that is frequently updated and refreshed.

The company says the average age of its superapp users is 39, with female users making up 62.8% of its user base. Its monetization strategy includes sales of video advertising, sponsored posts, banner ads and premium listings, as well as promotion of featured brands and property listings.

Market Opportunity

A report from Allied Market Research, a global market research, consulting and advisory firm, estimated that the worldwide superapps market was valued at $58.6 billion in 2022. The report projects the market to expand to $722.4 billion by 2032, growing at a CAGR of 28.9% for the forecast period.

The report identifies a few of the most popular superapps as Rappi in Latin America, Snapp in Iran, Line in Japan and Yandex Go in Russia and Kazakhstan.

Increasing adoption of mobile services and growing advancements in digital technologies are driving the growth of this market. In addition, a rise in government support for promoting the use of superapps is lending to expansion, according to the report.

Integration of blockchain technology in superapps is likewise anticipated to provide numerous opportunities for the expansion of the market during the forecast period, the report states.

Management Team

Joseph Onyero is Founder and CEO of Bebuzee. He has a background of managing multiple products from ideation to market launch and profitable monetization and has been building commercial web presences since 2005. He has worked as a Chief Marketing Officer and in business development. He previously owned and operated a travel and tourism company. He began in 2005 working on the concept and features that have evolved into the Bebuzee suite. He has grown Bebuzee from a living room start-up into a U.S. publicly traded company.

Claudia S. Spagnuolo is Chief Operating Officer at Bebuzee. She began with the company in 2014 as a user experience manager before being promoted to CMO in 2017. She previously worked as an assistant marketing director at the National Secretariat of the union CISL in Italy. Prior to that, she also worked as a researcher at the Complutense University of Madrid on issues of corporate management. She speaks three languages and holds a bachelor’s in political science and a master’s in administration from the University of Perugia in Italy.

Bebuzee Inc. (OTC: BBUZ), closed Monday's trading session at $0.039375, up 12.1795%, on 18,000 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.026/$0.359.

Recent News

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer

 

With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service

 

D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Monday's trading session at $1.2, up 15.3846%, on 10,079,488 volume. The average volume for the last 3 months is 3.728M and the stock's 52-week low/high is $0.57/$2.44.

Recent News

HeartBeam Inc. (NASDAQ: BEAT)

The QualityStocks Daily Newsletter would like to spotlight HeartBeam Inc. (NASDAQ: BEAT) .

HeartBeam Inc. (NASDAQ: BEAT) is a cardiac technology company that has developed the first and only 3D-vector 12-lead electrocardiogram (ECG) platform for heart attack detection anytime, anywhere. The company’s proprietary ECG telehealth technology aims to redefine the way high risk cardiovascular patients are diagnosed in ambulatory and acute care settings. HeartBeam’s initial focus is on providing diagnostic data to help physicians with care management of patients with cardiovascular disease.

In August 2022, HeartBeam announced that it submitted its HeartBeam AIMI™ software for approval from the U.S. Food and Drug Administration (FDA). HeartBeam AIMI is a platform technology to improve the speed and accuracy of heart attack detection in acute care settings. The company expects FDA approval by the end of 2022, and a full commercial roll-out of HeartBeam AIMI is targeted for Q1 2023.

HeartBeam sees submission of its first product based on its platform technology as an important milestone toward commercialization, which underscores the company’s continued progress toward making the HeartBeam AIMI platform widely available to help emergency department physicians quickly and accurately identify a heart attack.

While the FDA conducts its regulatory review, HeartBeam will focus on executing key components of its commercialization plan and subscription revenue model. It will also continue to engage in discussions with strategic institutions, including academic centers, regional healthcare systems and regional community hospital systems that can utilize HeartBeam products.

The company is based in Santa Clara, California.

Products

HeartBeam’s development portfolio includes two products:

  • HeartBeam AIMI is software that provides a 3D comparison of baseline and symptomatic 12-lead ECG to more accurately identify a heart attack in acute care settings and, as noted above, has been submitted for FDA approval; and
  • HeartBeam AIMIGo™, the first and only credit card-sized 12-lead output ECG device coupled with a smartphone app and cloud-based diagnostic software system for remote heart attack detection.

HeartBeam is developing AIMIGo, a medical-grade detection and monitoring technology for use in remote heart attack detection, thereby allowing physicians to diagnose a patient’s heart attack as it occurs, even if the patient is not at a medical facility. The company’s system, once approved by the FDA, can be used by patients at home or almost anywhere and anytime to help their physicians assess whether chest pain is the result of a heart attack or another cause. While approximately 82% of chest pain ED visits are unnecessary, patients delay approximately 3 to 4 hours after symptoms begin, increasing mortality rates by 40%. The company’s goal is to shorten the time to treatment outside of the medical facility to improve patients’ well-being.

HeartBeam’s AIMIGo is a powerful, portable and easy-to-use prescription-based product. It comprises a smartphone app, a credit card-sized ECG device placed on a patient’s chest, the HeartBeam cloud platform, and a digital portal for the physician to view ECG results and direct patient action. For the first time outside of a medical setting, HeartBeam AIMIGo enables patients and their clinicians to determine if symptoms are due to a heart attack, quickly and easily, so care can be expedited, if needed.

Pending FDA clearance, AIMIGo is initially intended to be available by prescription, and is reimbursable under existing remote patient monitoring codes (RPM codes). This provides a new revenue stream to physicians who before did not have a way to monitor these high-risk patients. The RPM codes provide a monthly reoccurring revenue stream to the company, as well. On average, at current reimbursement rates, the practice will receive $1,300+ per year per patient they monitor, and the company will receive $600 per year per patient from this RPM reimbursement.

Market Overview

Adoption rates of telehealth services increased dramatically in recent years, with the COVID-19 pandemic serving as a major driver of growth. Among the areas seeing the greatest expansion are cardiology, radiology, behavioral health and online consultation.

Encouraging this growth, governments are actively developing new policies and reimbursement guidelines to promote the use of digital health platforms. The U.S. Centers for Medicare & Medicaid Services (CMS), for example, has recently expanded reimbursement for telehealth services. U.S. market growth is also being driven by the rising prevalence of chronic conditions and the growing geriatric population.

Remote heart attack detection is a previously unsolved problem with a massive and underserved market that is several times larger than the $2 billion total addressable market (TAM) in the U.S. for ECG cardiac arrhythmia monitoring.

Approximately 8 million Americans have suffered at least one heart attack, and a total of 18 million have been diagnosed with coronary artery disease (CAD). Based on these figures, HeartBeam projects a total addressable U.S. market TAM valued at $10 billion annually for its AIMIGo solution for remote heart attack monitoring of CAD.

Management Team

Branislav Vajdic, Ph.D., Chief Executive Officer and Founder of HeartBeam, Inc, combines over 30 years of experience in technology development and senior management positions. Dr. Vajdic has been deeply involved with the development of HeartBeam’s technology to fit his vision for the company. Prior to HeartBeam, from 2007 to 2010, Dr. Vajdic was CEO and Founder of NewCardio, a publicly traded company in the cardiovascular devices space. From 1984 to 2007, Dr. Vajdic was at Intel, where he held various senior management position. At Intel, Dr. Vajdic was the designer of first Flash memory and two key inventions that enabled Flash as a product and led engineering groups responsible for Pentium 1 through Pentium 4 designs. Dr. Vajdic was awarded two Intel Achievement Awards, the highest level of award for outstanding contributions to Intel. Dr. Vajdic is author of numerous patents and publications in the fields of cardiovascular devices, as well as chip design. Dr. Vajdic holds a Ph.D. in Electrical Engineering from the University of Minnesota.

Jon Hunt, Ph.D., has over 35 years’ experience in the medical/medical device industry with extensive domestic and international experience in general management, clinical/regulatory, sales and marketing. He also has diverse experience in Fortune 500 companies, as well as start-up environments. Dr. Hunt was the Vice President of Clinical Science and Technology, Medical Device Innovation Consortium, from July 2019 to July 2021, and Vice President of Clinical and Regulatory Affairs, Cryterion Medical from January 2018 to June 2019 (acquired by Boston Scientific Corporation in July 2018 for $202M). Dr. Hunt was the Founding President and CEO of Bardy Diagnostics, Inc. from October 2013 to November 2017 (acquired by Hill-Rom Holdings, Inc.). Prior to joining Bardy Diagnostics, Dr. Hunt spent the previous 11 years as the Vice President of Clinical & Regulatory Affairs with Cameron Health, Inc. (acquired by Boston Scientific Corporation). Dr. Hunt spent the previous 10 years with Cardiac Pacemakers, Inc., St. Jude Medical and Cardiac Pathways Corporation. Dr. Hunt began his career with Cardiac Pacemakers, Inc. (now Boston Scientific Corporation) as the Director of Clinical Programs. He subsequently held positions at St. Jude Medical in Clinical Affairs and as the Business Unit Director for the Cardiac Rhythm Management division for Europe, the Middle East and Africa. At Cardiac Pathways Corporation, Dr. Hunt held various executive positions as Vice President of International Sales and Marketing and Vice President of Worldwide Sales and Marketing (acquired by Boston Scientific Corporation). Dr. Hunt received his Ph.D. in Motor Control from The Pennsylvania State University, his Master’s from California State University, Long Beach and his undergraduate degree from Keele University in the United Kingdom.

Rick Brounstein, HeartBeam’s Chief Financial Officer, combines over 30 years of experience in health technology senior management. Since 2017, Mr. Brounstein has been and is currently a partner of Hardesty, LLC, a financial services firm, and Mr. Brounstein is currently a managing director of CTRLCFO, LLC, a firm Mr. Brounstein founded in 2016 to support funded start-ups in life science and technology. From 2008 to 2011, Mr. Brounstein was Chief Financial Officer of NewCardio, Inc., a microcap public company in the cardiology space, and, over his career, he has been with nine other companies in life science or technology, holding positions including Chief Financial Officer, Chief Operating Officer, Treasurer and Accounting Manager. From June 2001 through November 2007, Mr. Brounstein held several positions at Calypte Biomedical Corporation, a publicly traded medical device company, including Chief Financial Officer and Executive Vice President. In January 2007, Mr. Brounstein was appointed as the National Member Representative for the 2007 COSO Monitoring Project, which published new guidelines for monitoring internal financial controls in February 2009; Mr. Brounstein subsequently was a member of the FEI task force that issued the updated COSO Internal Control Framework in 2013. In March 2005, Mr. Brounstein was appointed to the SEC Advisory Committee on Smaller Public Companies. Mr. Brounstein earned his Certified Public Accountant (CPA) certification while working at Arthur Andersen LLP, formerly a public accounting firm. Mr. Brounstein holds a B.A. in accounting and an M.B.A. in finance, both from Michigan State University.

Ken Persen, HeartBeam’s Chief Technology Officer, combines over 28 years of experience in the medical device and digital health industries in engineering and senior management positions. Mr. Persen has been involved in several companies in Cardiac Rhythm Management, holding positions including Chief Executive Officer, Chief Technology Officer, Executive Vice President and Director of Engineering. Since 2016 and prior to joining HeartBeam, Mr. Persen was the Chief Technology Officer at LIVMOR, Inc., a digital health company. In addition, from 2016 through November 2021, he was also Chief Executive Officer of LIVMOR. Prior roles included Director of Engineering at Cameron Health (acquired by Boston Scientific), a late-stage medical device start up, and engineering and management positions at Guidant Corp. (acquired by Boston Scientific), a large medical device manufacturer. He has an undergraduate degree from University of Minnesota, Duluth, with a BA in Computer Science.

HeartBeam Inc. (NASDAQ: BEAT), closed Monday's trading session at $2.44, up 0.4115226%, on 44,435 volume. The average volume for the last 3 months is 68,646 and the stock's 52-week low/high is $1.06/$3.3893.

Recent News

CNS Pharmaceuticals Inc. (NASDAQ: CNSP)

The QualityStocks Daily Newsletter would like to spotlight CNS Pharmaceuticals Inc. (NASDAQ: CNSP).

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system.

The company was founded in 2017 and is headquartered in Houston, Texas.

Organ Targeted Therapeutics

The company’s lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin also has potential to treat other central nervous system malignancies. Based on limited clinical data, Berubicin appears to be the first anthracycline to cross the blood brain barrier in the adult brain, and it was the subject of a successful Phase 1 study which found the MDT and produced efficacy data as well.

CNS holds a worldwide exclusive license to the Berubicin chemical compound. The company has acquired all requisite data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase I clinical trial of Berubicin in malignant brain tumors. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. In 2017, CNS entered into a collaboration and asset purchase agreement with Reata.

CNS intends to explore the potential of Berubicin to treat other diseases, including pancreatic and ovarian cancers and lymphoma. The company is also examining plans to develop combination therapies that include Berubicin.

CNS estimates that more than $25 million in private capital and grants were invested in Berubicin prior to the company’s $9.8 million IPO in November 2019.

CNS intends to submit an IND for Berubicin during the fourth quarter of 2020 and expects to commence a Phase II clinical trial of Berubicin for the treatment of GBM in the U.S. in Q1 2021. A sub-licensee partner was awarded a $6 million EU/Polish National Center for Research and Development grant to undertake a Phase II trial of Berubicin in adults and a first-ever Phase I trial in pediatric GBM patients in Poland in 2021.

The company’s second drug candidate, WP1244, is a novel DNA binding agent licensed from the MD Anderson Cancer Center. In preclinical studies, WP1244 proved to be 500-times more potent than the chemotherapeutic agent, daunorubicin, in inhibiting tumor cell proliferation. The company has entered into a sponsored research agreement with the MD Anderson Cancer Center to further the development of WP1244.

CNS Pharmaceuticals recently engaged U.S.-based Pharmaceutics International Inc. and Italian BSP Pharmaceuticals SpA for the production of the Berubicin drug product. The company has implemented a dual-track manufacturing strategy to mitigate COVID-19-related risks, diversify its supply chain and provide for localized availability of Berubicin. CNS has already completed synthesis of Berubicin’s active pharmaceutical ingredient (API) and has shipped the API to both manufacturers in order to prepare an injectable form of Berubicin for clinical use.

Global Brain Tumor Therapeutics Market

The high recurrence rate of malignant brain tumors is due to reappearance of focal masses, indicating that a sub-population of tumor cells in these cancers may be insensitive to current therapies and may be responsible for reinitiating tumor growth. This necessitates the development of newer drugs in the market that demonstrate greater efficacy in treating such aggressive cancers.

A global increase in neurological disorders has placed increased attention on cancers of the brain over the past decade. Neurological disorders are becoming one of the most prevalent types of disorders, due to longer life expectancy, greater exposure to infection and an increasingly sedentary lifestyle. Because few treatments for primary and metastatic cancers of the brain exist, costs are high and have acted as a restraint for the brain tumor therapeutics market.

Despite progress in surgery, radiotherapy and chemotherapeutic strategies, effective treatments for brain cancer are limited by a lack of specific therapies for the brain and the difficulty in transporting therapeutic compounds across the blood brain barrier. Therefore, there is a significant need for novel and effective therapeutic drugs and strategies that prolong survival and improve quality of life for brain tumor patients.

Several companies are making significant investments into R&D, which is expected to bring more treatment options to the market in the near future. Industry reports consistently project continued growth in the market.

One report estimates that the global brain tumor therapeutics market will reach a valuation of $2.74 billion in 2023, with the market expected to register a CAGR of 11% during the forecast period from 2018 to 2023. Another report projects that the global brain tumor therapeutics market will reach $3.4 billion by 2025, up from $2.25 billion in 2019 (http://nnw.fm/eDUjp).

Management Team

John M. Climaco is the CEO of CNS Pharmaceuticals. For 15 years, Climaco has served in leadership roles for a variety of health care companies. Recently, Climaco served as the Executive Vice President of Perma-Fix Medical S.A, where he managed the development of a novel method to produce Technitium-99. Climaco also served as President and CEO of Axial Biotech Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization, Climaco forged strategic partnerships with Medtronic, Johnson & Johnson and Smith & Nephew.

Christopher Downs, CPA, is the company’s Chief Financial Officer. Downs previously served as Interim Chief Financial Officer and Executive Vice President of InfuSystem Holdings Inc. (NYSE: INFU), a supplier of infusion services to oncologists in the United States. Downs holds a Bachelor of Science from the United States Military Academy at West Point, an MBA from Columbia Business School and a Master of Science in Accounting from the University of Houston-Clear Lake.

Dr. Donald Picker is the Chief Scientific Officer of CNS. Picker has over 35 years of drug development experience. Prior to joining CNS, Picker worked at Johnson Matthey, where he was responsible for the development of Carboplatin, one of the world’s leading cancer drugs, which was acquired by Bristol-Myers Squibb with annual sales of over $500 million. In addition, he oversaw the development of Satraplatin and Picoplatin, third-generation platinum drugs currently in late-stage clinical development.

Sandra L. Silberman, M.D., Ph.D., is the Chief Medical Officer of CNS Pharmaceuticals. Silberman is a hematologist/oncologist who earned her B.A., Sc.M. and Ph.D. from the Johns Hopkins University School of Arts and Sciences, School of Public Health and School of Medicine, respectively, and her M.D. from Cornell University Medical College. She then completed both a clinical fellowship in hematology/oncology and a research fellowship in tumor immunology at the Brigham & Women’s Hospital and the Dana Farber Cancer Institute in Boston, Massachusetts. Silberman has played key roles in the development of many drugs, including Gleevec(TM), for which she led the global clinical development at Novartis. Silberman advanced several original, proprietary compounds into Phases I through III during her work with leading biopharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, Imclone and Roche.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), closed Monday's trading session at $0.145, up 9.6823%, on 13,877,830 volume. The average volume for the last 3 months is 15.476M and the stock's 52-week low/high is $0.0955/$6875.00.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.